<SEC-DOCUMENT>0001539497-25-002056.txt : 20250807
<SEC-HEADER>0001539497-25-002056.hdr.sgml : 20250807
<ACCEPTANCE-DATETIME>20250807171944
ACCESSION NUMBER:		0001539497-25-002056
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		13
FILED AS OF DATE:		20250807
DATE AS OF CHANGE:		20250807

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MDU RESOURCES GROUP INC
		CENTRAL INDEX KEY:			0000067716
		STANDARD INDUSTRIAL CLASSIFICATION:	MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400]
		ORGANIZATION NAME:           	01 Energy & Transportation
		EIN:				301133956
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-289348
		FILM NUMBER:		251195393

	BUSINESS ADDRESS:	
		STREET 1:		1200 WEST CENTURY AVENUE
		CITY:			BISMARCK
		STATE:			ND
		ZIP:			58503
		BUSINESS PHONE:		701-530-1000

	MAIL ADDRESS:	
		STREET 1:		1200 WEST CENTURY AVENUE
		CITY:			BISMARCK
		STATE:			ND
		ZIP:			58503

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MONTANA DAKOTA UTILITIES CO
		DATE OF NAME CHANGE:	19850429
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>n5198_x2-424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-size: 10pt"><B>Filed Pursuant to
Rule 424(b)(5)<BR>
Registration No. 333-289348</B></FONT><B> </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 9pt"><B>PROSPECTUS SUPPLEMENT </B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 9pt"><B>(To Prospectus Dated August 7, 2025)</B></FONT><B>
</B></P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center"><FONT STYLE="font-size: 16pt"><B>Up to $400,000,000</B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><IMG SRC="mduresourceslogo.jpg" ALT=""></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center"><FONT STYLE="font-size: 20pt"><B>MDU Resources
Group, Inc.</B></FONT><B> </B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Common Stock</B></FONT></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0pt 8pt"><FONT STYLE="font-size: 9pt">We may issue, offer and sell up to an
aggregate of $400,000,000 of our common stock, $1.00 par value per share (&#8220;common stock&#8221;) from time to time through Wells
Fargo Securities, LLC (&#8220;Wells Fargo&#8221;) and BofA Securities, Inc. (&#8220;BofA Securities&#8221;), as our agents under a distribution
agreement entered into on August 7, 2025 (the &#8220;equity distribution agreement&#8221;). We refer to Wells Fargo and BofA Securities,
together, as the &#8220;sales agents.&#8221;</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0pt 8pt"><FONT STYLE="font-size: 9pt">Under the equity distribution agreement,
we may also sell shares of our common stock to the applicable sales agent, as principal for its own account, at a price to be agreed
upon at the time of sale. If we sell our shares of common stock to either sales agent, as principal for its own account, we will enter
into a separate terms agreement with such sales agent, and we will describe such agreement in a separate prospectus supplement or pricing
supplement. The equity distribution agreement provides that, in addition to the issuance and sale of shares of our common stock by us
through the applicable sales agent, we also may enter into forward sale agreements under a separate master forward sale confirmation
and related supplemental confirmation between us and such sales agent or its affiliate, which we refer to as the forward counterparty.
In connection with each forward sale agreement, the relevant forward counterparty (or its affiliate) will, at our request, attempt to
borrow from third parties and, through the relevant sales agent, sell a number of shares of our common stock equal to the number of shares
of our common stock that underlie the forward sale agreement to hedge the forward sale agreement. We entered into master forward sale
confirmations with each of the forward counterparties on August 7, 2025.</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0pt 8pt"><FONT STYLE="font-size: 9pt">In no event will the aggregate number
of shares of our common stock sold through the sales agents, as our agents and as, or on behalf of, the forward counterparties, under
the equity distribution agreement have an aggregate gross sales price in excess of $400,000,000. The offering of our common stock pursuant
to the equity distribution agreement will terminate upon the earliest of (1) the sale, under the equity distribution agreement, of shares
of our common stock with an aggregate gross sales price equal to $400,000,000 and (2) the termination of the equity distribution agreement,
pursuant to its terms, by us, the sales agents, or the forward counterparties.</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0pt 8pt"><FONT STYLE="font-size: 9pt">We will not initially receive any proceeds
from the sale of borrowed shares of our common stock by a forward counterparty or its related sales agent, as applicable. We expect to
receive proceeds from the sale of shares of our common stock upon future physical settlement of the relevant forward sale agreement with
the relevant forward counterparty on dates specified by us on or prior to the maturity date of the relevant forward sale agreement. If
we elect to cash settle or net share settle under a forward sale agreement, we may not (in the case of cash settlement) or will not (in
the case of net share settlement) receive any proceeds, and we may owe cash (in the case of cash settlement) or shares of our common
stock (in the case of net share settlement) to the relevant forward counterparty.</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0pt 8pt"><FONT STYLE="font-size: 9pt">The shares of our common stock to which
this prospectus supplement relates may be offered and sold by any method permitted by law to be an &#8220;at the market offering&#8221;
as defined in Rule 415 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), including by means of ordinary
brokers&#8217; transactions on the New York Stock Exchange (the &#8220;NYSE&#8221;), the existing trading market for our shares of common
stock, or otherwise at market prices prevailing at the time of sale, or sales made to or through a market maker or through an electronic
communications network. In addition, shares of our common stock may be offered and sold by such other methods, including privately negotiated
transactions (including block trades), as we and any sales agent agree to in writing. The sales agents are not required to sell any specific
number or dollar amount of shares of our common stock, but each of them and the forward counterparty, as applicable, will use its commercially
reasonable efforts to sell shares designated by us in accordance with the equity distribution agreement. The sales agents will not engage
in any transactions that stabilize our common stock. There is no arrangement for funds to be received in an escrow, trust or similar
arrangement.</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0pt 8pt"><FONT STYLE="font-size: 9pt">We will pay each sales agent a commission
of up to 1.0% of the sales price of all shares of our common stock sold through it as our sales agent under the equity distribution agreement.
The commission we pay to any sales agent for sales by privately negotiated transactions (including block trades) or other methods may
vary, as we and any sales agent agree to in writing. The remaining sales proceeds, after deducting any expenses payable by us and any
transaction fees imposed by any governmental, regulatory or self-regulatory organization in connection with the sales, will be our net
proceeds for the sale of the shares. In connection with each forward sale agreement, the relevant forward counterparty will receive,
reflected in a reduced initial forward sale price payable by the relevant forward counterparty</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 8pt"><FONT STYLE="font-size: 9pt">under its forward sale agreement, a
commission of up to 1.0% of the volume weighted average of the sales prices of all borrowed shares of our common stock sold during the
applicable period by it (or its related sales agent, as applicable) as a forward counterparty.</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0pt 4pt"><FONT STYLE="font-size: 9pt">We list our common stock on the NYSE
under the symbol &#8220;MDU&#8221;. On August 6, 2025, the last reported sale price of our common stock on the NYSE was $17.49 per
share.</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0pt 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><B>Investing
in our common stock involves risks. See &#8220;<FONT STYLE="color: #0000EE"><U>Risk Factors</U></FONT>&#8221; beginning on page S-4
of this prospectus supplement and in the documents incorporated by reference herein to read important factors you should consider
before investing in our common stock. </B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0"><FONT STYLE="font-size: 10pt"><B>Neither the Securities and Exchange
Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the adequacy or accuracy of this
prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.</B></FONT><B> </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; margin-top: 5pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Wells Fargo Securities</B></FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt"><B>BofA Securities</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: center"><FONT STYLE="font-size: 9pt"><B>The date of this
prospectus supplement is August 7, 2025</B></FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>




<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center">PROSPECTUS SUPPLEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 8pt Times New Roman, Times, Serif; width: 95%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 90%"><FONT STYLE="font-size: 10pt">&thinsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 10%; white-space: nowrap; text-align: right">&thinsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">&thinsp;</FONT></TD>
    <TD STYLE="padding-right: 0pt; white-space: nowrap; vertical-align: top; text-align: right; padding-left: 0pt"><FONT STYLE="font-size: 8pt"><B><U>&nbsp;&nbsp;Page&nbsp;&nbsp;</U></B></FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">ABOUT THIS PROSPECTUS SUPPLEMENT</FONT></A></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">S-i</FONT></A></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">CAUTIONARY NOTE REGARDING
    FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">S-ii</FONT></A></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">SUMMARY</FONT></A></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">S-1</FONT></A></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">THE OFFERING</FONT></A></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">S-2</FONT></A></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">S-4</FONT></A></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">S-8</FONT></A></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">MATERIAL U.S. FEDERAL INCOME
    AND ESTATE TAX CONSIDERATIONS FOR NON-U.S. HOLDERS</FONT></A></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">S-9</FONT></A></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">PLAN OF DISTRIBUTION (CONFLICTS
    OF INTEREST)</FONT></A></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right"><A HREF="#a_008"><FONT STYLE="font-size: 10pt">S-13</FONT></A></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">WHERE YOU CAN FIND MORE
    INFORMATION</FONT></A></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">S-19</FONT></A></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">S-20</FONT></A></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt"><A HREF="#a_011"><FONT STYLE="font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right"><A HREF="#a_011"><FONT STYLE="font-size: 10pt">S-20</FONT></A></TD>
    </TR>

<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="2" STYLE="vertical-align: bottom">&nbsp;<P STYLE="font: 8pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">PROSPECTUS</FONT></P>

</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right">&nbsp;</TD></TR>

<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: right">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 94%; padding-top: 1.5pt"><FONT STYLE="font-size: 10pt">&thinsp;</FONT></TD>
    <TD STYLE="width: 6%; padding-top: 1.5pt; padding-right: 3pt; padding-left: 1.5pt; text-align: right"><FONT STYLE="font-size: 10pt"><U>Page</U></FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_001"><FONT STYLE="font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_001"><FONT STYLE="font-size: 10pt">i</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_002"><FONT STYLE="font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_002"><FONT STYLE="font-size: 10pt">ii</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_003"><FONT STYLE="font-size: 10pt">MDU RESOURCES GROUP, INC.</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_003"><FONT STYLE="font-size: 10pt">1</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_004"><FONT STYLE="font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_004"><FONT STYLE="font-size: 10pt">2</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_005"><FONT STYLE="font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_005"><FONT STYLE="font-size: 10pt">3</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_006"><FONT STYLE="font-size: 10pt">DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_006"><FONT STYLE="font-size: 10pt">4</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_007"><FONT STYLE="font-size: 10pt">DESCRIPTION OF DEBT SECURITIES</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_007"><FONT STYLE="font-size: 10pt">7</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_008"><FONT STYLE="font-size: 10pt">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_008"><FONT STYLE="font-size: 10pt">8</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_009"><FONT STYLE="font-size: 10pt">DESCRIPTION OF PURCHASE CONTRACTS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_009"><FONT STYLE="font-size: 10pt">9</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_010"><FONT STYLE="font-size: 10pt">DESCRIPTION OF UNITS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_010"><FONT STYLE="font-size: 10pt">10</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_011"><FONT STYLE="font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_011"><FONT STYLE="font-size: 10pt">11</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_012"><FONT STYLE="font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_012"><FONT STYLE="font-size: 10pt">13</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_013"><FONT STYLE="font-size: 10pt">INFORMATION INCORPORATED BY REFERENCE</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_013"><FONT STYLE="font-size: 10pt">13</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_014"><FONT STYLE="font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_014"><FONT STYLE="font-size: 10pt">14</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_015"><FONT STYLE="font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_015"><FONT STYLE="font-size: 10pt">14</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0"></P>




<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_001" TITLE="ABOUT THIS PROSPECTUS SUPPLEMENT"></A><B>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This prospectus supplement is part of a registration statement that
we filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) using a &#8220;shelf&#8221; registration process. Under
the shelf registration process, we may, from time to time, issue and sell to the public the securities described in the accompanying prospectus,
including the common shares, of which this offering is a part. In this prospectus supplement, we provide you with specific information
about the terms of the shares of common shares and this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This document is in two parts. The first part is this prospectus
supplement, which describes the specific terms of this offering of common stock. The second part, the accompanying prospectus, gives more
general information, some of which may not apply to this offering. You should read the entire prospectus supplement, as well as the accompanying
prospectus and the documents incorporated by reference that are described under &#8220;Where You Can Find More Information&#8221; in this
prospectus supplement. In the event that the description of the offering varies between this prospectus supplement and the accompanying
prospectus, you should rely on the information contained in this prospectus supplement. Generally, when we refer to the &#8220;prospectus,&#8221;
we are referring to this prospectus supplement and the accompanying prospectus combined.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">You should rely only on the information contained in this document
or to which this document refers you, or in other offering materials filed by us with the SEC. This prospectus supplement, the accompanying
prospectus and any free writing prospectus that we prepare or authorize contain and incorporate by reference information that you should
consider when making your investment decision. We have not, and the sales agents and forward counterparties have not, authorized anyone
to provide you with different information. We take no responsibility for, and can provide no assurance as to the reliability of, any different
or inconsistent information. This document may only be used where it is legal to sell these securities. We are not, and the sales agents
and the forward counterparties are not, making an offer of these securities in any jurisdiction where the offer is not permitted. You
should not assume that the information in this prospectus supplement, the accompanying prospectus, or the documents incorporated by reference
herein or therein is accurate as of any date other than the date of those documents. Our business, financial condition, results of operations,
and prospects may have changed since the date of such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We further note that the representations, warranties and covenants
made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference in this prospectus supplement
or the accompanying prospectus were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose
of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you.
Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations,
warranties and covenants should not be relied on as accurately representing the current state of our affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Unless we indicate otherwise, or the context otherwise requires,
references in this prospectus supplement to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our,&#8221; or similar
terms are to MDU Resources Group, Inc. and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&thinsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="a_002" TITLE="CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">This prospectus supplement, the accompanying prospectus, the
documents that we incorporate by reference herein and therein and any related free writing prospectus issued by us may contain
forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act
of 1934, as amended (the &#8220;Exchange Act&#8221;). Other than statements of historical facts, all statements which address
activities, events, or developments that the Company anticipates will or may occur in the future are based on underlying assumptions
(many of which are based, in turn, upon further assumptions), including, but not limited to, statements identified by the words
&#8220;anticipates,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; and
&#8220;predicts&#8221; in each case related to such things as growth estimates, stockholder value creation, the Company&#8217;s
&#8220;CORE&#8221; strategy, capital expenditures, financial guidance, trends, objectives, goals, dividend payout ratio targets,
strategies and other such matters, are forward-looking statements. These forward-looking statements are based on many assumptions
and factors, which are detailed in the Company&#8217;s filings with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">While made in good faith, these forward-looking statements are
based largely on the Company&#8217;s expectations and judgments and are subject to a number of risks and uncertainties, many of which
are unforeseeable and beyond the Company&#8217;s control. For additional discussion regarding risks and uncertainties that may affect
forward-looking statements, see Part I, Item 1A. Risk Factors in the Company&#8217;s <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000016/mdu-20241231.htm"><FONT STYLE="color: blue">Annual
Report on Form 10-K for the year ended December 31, 2024</FONT></A>, Part II, Item 1A. Risk Factors in the Company&#8217;s <FONT STYLE="background-color: white">Quarterly
Reports on Form&nbsp;10-Q for the quarters ended </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000042/mdu-20250331.htm"><FONT STYLE="background-color: white">March
31, 2025</FONT></A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/67716/000006771625000074/mdu-20250630.htm">June 30, 2025</A> and subsequent filings with the SEC. Any changes in such assumptions or factors could
produce significantly different results. Undue reliance should not be placed on forward-looking statements, which speak only as of the
date they are made. Except as required by applicable law, the Company undertakes no obligation to update the forward-looking statements,
whether as a result of new information, future events, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>



<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: Black 1pt solid; padding-left: 1%; padding-right: 1%; width: 98%">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="a_003" TITLE="SUMMARY"></A>SUMMARY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><I>This summary does not contain all of the information that you
should consider before investing in our common stock. You should read the following summary in conjunction with the more detailed information
contained elsewhere in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference in this prospectus
supplement and the accompanying prospectus.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>ABOUT THE COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The Company is a pure-play regulated energy delivery business upon
the completed separations of both its construction materials and contracting and construction services businesses. The Company generates,
transmits and distributes electricity and provides natural gas distribution, transportation and storage services. Through a strategy focusing
on its &#8220;CORE,&#8221; the Company strives to deliver superior value and achieve industry-leading performance as a pure-play regulated
energy delivery company, while pursuing organic growth opportunities. The Company&#8217;s &#8220;CORE&#8221; strategy prioritizes customers
and communities, operational excellence, returns focused initiatives and an employee driven culture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Montana-Dakota Utilities Co. (formerly known as MDU Resources Group,
Inc., &#8220;Montana-Dakota&#8221;) was incorporated under the laws of the state of Delaware in 1924. The Company was incorporated under
the laws of the state of Delaware in 2018. Upon the completion of an internal holding company reorganization, Montana-Dakota became a
subsidiary of the Company. Our principal executive offices are located at 1200 West Century Avenue, P.O. Box 5650, Bismarck, North Dakota
58506-5650, telephone (701) 530-1000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><FONT STYLE="font-size: 10pt">S-1</FONT></P>

</div>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<div STYLE="BORDER:solid BLACK 1pt;padding-left:1%;padding-Right:1%;width:98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B><A NAME="a_004" TITLE="THE OFFERING"></A>THE OFFERING</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2.5in; padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Common stock offered by this<BR>
 prospectus supplement</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Shares of our common stock with an aggregate gross sales price of up to $400,000,000.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Manner of Offering</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">&#8220;At the market offering&#8221; that may be made from time to time through the sales agents. In addition to the issuance and sale of shares of our common stock by us through the applicable sales agents, we also may enter into forward sale agreements under separate master forward sale confirmations and related supplemental confirmations between us and the forward counterparties. In connection with each forward sale agreement, the relevant forward counterparty (or its affiliate) will, at our request, attempt to borrow from third parties and, through the relevant sales agent, sell a number of shares of our common stock equal to the number of shares of our common stock that underlie the forward sale agreement to hedge the forward sale agreement. See &#8220;Plan of Distribution (Conflicts of Interest).&#8221; In addition, shares of our common stock may be offered and sold by such other methods, including privately negotiated transactions (including block trades) as we and any sales agent agree to in writing.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Use of Proceeds</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We intend to use the net proceeds that we receive upon the issuance
    and sale of shares of our common stock for general corporate purposes, which may include repayment or refinancing of debt, acquisitions,
    working capital, capital expenditures, and repurchases or redemptions of securities. See &#8220;Use of Proceeds.&#8221;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We will not initially receive any proceeds from the sale of borrowed
    shares of our common stock by the forward counterparties (or their related sales agents, as applicable) as a hedge in connection with
    any forward sale agreement. We intend to use any cash proceeds that we receive upon physical settlement of any forward sale agreement,
    if physical settlement applies, or upon cash settlement of any forward sale agreement, if we elect cash settlement, for the purposes described
    above.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Listing</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Our common stock is listed on the NYSE under the symbol &#8220;MDU&#8221;.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Transfer Agent and Registrar</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">The transfer agent and registrar for our common stock is Equiniti Trust Company, LLC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Dividend Policy</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">The Company has an 87-year history of uninterrupted dividend payments to stockholders and remains committed to paying a competitive dividend in the established long-term dividend payout ratio target range of 60 percent to 70 percent of regulated energy delivery earnings. The Company depends on earnings and dividends from its subsidiaries to pay dividends on common stock. The declaration and payment of dividends is at the sole discretion of the board of directors, subject to limitations imposed by agreements governing the Company&#8217;s indebtedness, federal and state laws, and applicable regulatory limitations. &thinsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Material U.S. Federal Income <BR>
and Estate Tax Considerations <BR>
for Non-U.S. Holders</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Material U.S. federal income and estate tax considerations of the acquisition, ownership, and disposition of our common stock that are relevant for&thinsp;non-U.S.&thinsp;holders are described in &#8220;Material U.S. Federal Income and Estate Tax Considerations for&thinsp;Non-U.S.&thinsp;Holders&#8221; included elsewhere in this prospectus supplement.</FONT></TD></TR>
  </TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 12pt"><FONT STYLE="font-size: 10pt">S-2</FONT></P>

</div>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<div STYLE="BORDER:solid BLACK 1pt;padding-left:1%;padding-Right:1%;width:98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2.5in; padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Risk Factors</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">You should read &#8220;Risk
    Factors&#8221; on page&thinsp;S-4&thinsp;of this prospectus supplement, on page 2 of the accompanying prospectus, and in the
    documents incorporated by reference herein for a discussion of certain risks that prospective investors should consider before
    investing in our common stock.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Accounting Treatment</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">In the event that we enter into any forward sale agreement, we expect that before the issuance of shares of our common stock, if any, upon settlement of any forward sale agreement, the shares issuable upon settlement of that particular forward sale agreement will be reflected in our diluted earnings per share calculations using the treasury stock method. Under this method, the number of shares of our common stock used in calculating diluted earnings per share is deemed to be increased by the excess, if any, of the number of shares of our common stock that would be issued upon full physical settlement of that particular forward sale agreement over the number of shares of our common stock that could be purchased by us in the market (based on the average market price of our common stock during the applicable reporting period) using the proceeds receivable upon full physical settlement (based on the adjusted forward sale price at the end of the applicable reporting period). Consequently, we anticipate there will be no dilutive effect on our earnings per share except during periods when the average market price of shares of our common stock is above the then-applicable adjusted forward sale price under that particular forward sale agreement. Any issuance and delivery of our common stock by us upon any physical or net share settlement of any particular forward sale agreement, however, will result in dilution to our earnings per share.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">Conflicts of Interest</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 12pt; padding-left: 0pt"><FONT STYLE="font-size: 10pt">The forward counterparties (or their respective affiliates) will receive the net proceeds of any sale of borrowed shares of our common stock pursuant to this prospectus supplement in connection with any forward sale agreement. Because (i) certain sales agents or their affiliates are expected to receive part of the net proceeds from the sale of shares of our common stock in connection with any forward sale agreement, and (ii) some of the net proceeds of this offering or upon settlement of any forward sale agreement may be used to repay debt, which may include amounts outstanding under our or our subsidiaries&#8217; revolving credit facilities, in which case such sales agents may be deemed to have a conflict of interest under Rule 5121 of the Financial Industry Regulatory Authority (&#8220;FINRA&#8221;) to the extent such sales agents or affiliates receive at least 5% of the net proceeds of the offering. Any sales agent deemed to have a conflict of interest would be required to conduct the distribution of our common stock in accordance with FINRA Rule 5121. If the offering is conducted in accordance with FINRA Rule 5121, such sales agent would not be permitted to confirm a sale to an account over which it exercises discretionary authority without first receiving specific written approval from the account holder. See &#8220;Plan of Distribution (Conflict of Interest)&#8221; for additional information.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><FONT STYLE="font-size: 10pt">S-3</FONT></P>
</div>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="a_005" TITLE="RISK FACTORS"></A>RISK FACTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><I>Investing in our common stock involves risks. Before making a
decision to invest in our common stock, you should carefully consider the risks and uncertainties discussed in the following risk factors
and in &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221;, as well as in &#8220;Risk Factors&#8221; and &#8220;Cautionary
Note Regarding Forward-Looking Statements&#8221; in our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q,
and other filings we make from time to time with the SEC. You should also consider the risk factors described in any documents we incorporate
by reference in the future. See &#8220;Where You Can Find More Information.&#8221; </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Risks Related to our Common Stock and this Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B><I>The shares of our common stock offered hereby may be sold
in &#8220;at the market offerings&#8221;, and investors who buy shares of our common stock at different times will likely pay different
prices. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Investors who purchase shares of our common stock in this offering
at different times will likely pay different prices, and so may experience different levels of dilution and different outcomes in their
investment results. We will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares of our common
stock sold in this offering. Investors may experience a decline in the value of the shares of our common stock they purchase in this offering
as a result of sales made at prices lower than the prices they paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B><I>It is not possible to predict the aggregate proceeds resulting
from sales of our common stock made under the equity distribution agreement. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Subject to certain limitations in the equity distribution agreement
and compliance with applicable law, we have the discretion to deliver a transaction confirmation to the sales agents at any time throughout
the term of the equity distribution agreement. The number of shares of our common stock that are sold through the agents after delivering
a transaction confirmation will fluctuate based on a number of factors, including the market price of our common stock during the sales
period, the limits we set with the sales agents in any applicable transaction confirmation, and the demand for our common stock during
the sales period. Because the price per share of our common stock will fluctuate during the sales period, it is not currently possible
to predict the aggregate proceeds to be raised in connection with those sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B><I>Settlement provisions contained in a forward sale agreement
subject us to certain risks. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">With respect to any particular forward sale agreement we may enter
into, the relevant forward counterparty will have the right to accelerate settlement of a particular forward sale agreement (or, in certain
cases, the portion thereof that the relevant forward counterparty determines is affected by the relevant event) and require us to physically
settle that forward sale agreement on a date specified by the relevant forward counterparty if:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">in the good faith, commercially reasonable judgment of the forward counterparty, it, or its affiliate,
is unable to hedge its exposure to the transactions contemplated by its forward sale agreement because of the lack of sufficient shares
of our common stock being made available for borrowing by stock lenders, or it, or its affiliate, is unable to borrow such number of shares
at a rate equal to or less than an agreed maximum stock loan rate;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">we declare any dividend or distribution on shares of our common stock payable in (i) cash in excess
of a specified amount (other than an extraordinary dividend), (ii) securities of another company, or (iii) any other type of securities
(other than our common stock), rights, warrants, or other assets for payment (cash or other consideration) at less than the prevailing
market price, as reasonably determined by the forward counterparty;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">certain ownership thresholds applicable to the forward counterparty are exceeded;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">an event is announced that, if consummated, would result in an extraordinary event (as defined in the
forward sale agreement) including, among other things, certain mergers and tender offers, as well as certain</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 9; Options: NewSection; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">events such as a delisting of our common stock (each as more
fully described in the forward sale agreement); or</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">certain other events of default or termination events occur, including, among other things, any material
misrepresentation made by us in connection with our entry into the forward sale agreement, our bankruptcy (except as described below),
or certain changes in law (each as more fully described in the forward sale agreement).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">A forward counterparty&#8217;s decision to exercise its right to
accelerate settlement of a particular forward sale agreement (or, in certain cases, the portion thereof that it determines is affected
by the relevant event) and to require us to settle such forward sale agreement will be made irrespective of our interests, including our
need for capital. In such cases, we could be required to issue and deliver shares of our common stock under the terms of the physical
settlement provisions of the forward sale agreement irrespective of our capital needs, which would result in dilution to our earnings
per share and may adversely affect the market price of our common stock. In addition, upon certain events of bankruptcy or insolvency
relating to us, the relevant forward sale agreement will automatically terminate without further liability of either party to the agreement.
Following any such termination, we would not issue any shares of our common stock and we would not receive any proceeds pursuant to the
relevant forward sale agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We expect that settlement of any forward sale agreement will generally
occur no later than the date specified in the particular forward sale agreement. However, any forward sale agreement may be settled earlier
than that specified date in whole or in part at our option. We expect that each forward sale agreement will be physically settled by delivery
of shares of our common stock, unless we elect to cash settle or net share settle a particular forward sale agreement. Upon physical settlement
or, if we so elect, net share settlement of a particular forward sale agreement, delivery of shares of our common stock in connection
with such physical settlement or (to the extent we are obligated to deliver shares of our common stock) net share settlement will result
in dilution to our earnings per share and return on equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">In connection with any cash settlement or net share settlement,
we would expect the relevant forward counterparty or its affiliates to repurchase a number of shares of our common stock equal to the
portion for which we elect cash or net share settlement in order to satisfy their obligations to return the shares of our common stock
the relevant forward counterparty or its affiliates had borrowed in connection with sales of our common stock under this prospectus supplement
and, if applicable in connection with net share settlement, to deliver shares of our common stock to us. If the market value of our common
stock at the time of the purchase is above the adjusted forward sale price at that time, we will pay or deliver, as the case may be, to
the relevant forward counterparty under the relevant forward sale agreement, an amount in cash, or a number of shares of our common stock
with a market value, equal to such difference. Any such difference could be significant. Conversely, if the market value of our common
stock at the time of such purchase is below the forward sale price at that time, the relevant forward counterparty will pay or deliver,
as the case may be, to us under the relevant forward sale agreement, an amount in cash, or a number of shares of our common stock with
a market value, equal to such difference. See &#8220;Plan of Distribution (Conflicts of Interest)&#8212;Sales Through Forward Counterparties&#8221;
for information on the forward sale agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The forward sale price that we expect to receive upon physical settlement
of a particular forward sale agreement will be subject to adjustment on a daily basis based on an interest rate factor equal to
the overnight bank funding rate less a spread for a particular forward sale agreement and will be decreased based on amounts related to
expected dividends on shares of our common stock during the term of the particular forward sale agreement. If the overnight bank funding
rate is less than the spread on any day, the interest rate factor will result in a daily reduction of the applicable forward sale price
for such day. The applicable forward sale price will also be subject to decrease if the cost to the forward counterparty of borrowing
the number of shares of our common stock underlying the forward sale agreement exceeds a specified amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">In addition, the purchase of shares of our common stock by any forward
counterparty or its affiliates to unwind a forward counterparty&#8217;s hedge position could cause the price of our common stock to increase
over time, thereby increasing the amount of cash or the number of shares of our common stock that we would owe to the relevant forward
counterparty upon a cash settlement or net share settlement, as the case may be, of the particular forward sale agreement, or decreasing
the amount of cash or the number of shares of our common stock that such forward counterparty would owe us upon cash settlement or net
share settlement, as the case may be, of the particular</P>


<!-- Field: Page; Sequence: 10; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">forward sale agreement. We will not be able to control the manner
in which the relevant forward counterparty unwinds its hedge position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B><I>In certain bankruptcy or insolvency events, any forward sale
agreement will automatically terminate, and we would not receive the expected proceeds from any forward sales of our common stock. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">If we institute or consent to, or an appropriate regulatory or other
authority institutes against us, a proceeding seeking a judgment in bankruptcy or insolvency or any other relief under any bankruptcy
or insolvency law or other similar law affecting creditors&#8217; rights or if we or such authority presents a petition for our winding
up or liquidation or we consent to such a petition, any forward sale agreement that is then in effect will automatically terminate. If
any such forward sale agreement so terminates under these circumstances, we would not be obligated to deliver to the relevant forward
counterparty any shares of our common stock not previously delivered (or for which physical settlement has not been elected), and the
relevant forward counterparty would be discharged from its obligation to pay the applicable forward sale price per share in respect of
any shares of our common stock not previously settled (or for which physical settlement has not been elected). Therefore, to the extent
there are any shares of our common stock with respect to which we have not elected to physically settle under the forward sale agreement
at the time of the institution of or consent to any such bankruptcy or insolvency proceedings or any such petition, we would not receive
the relevant forward sale price per share in respect of those shares of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B><I>You may experience significant dilution as a result of this
offering or other future sales of our common stock, which may adversely affect the per share trading price of our common stock. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">This offering may have a dilutive effect on our earnings per share
after giving effect to the issuance of our common stock in this offering and the receipt of the expected net proceeds. The actual amount
of dilution from this offering, or from any future offering of our common or preferred stock, will be based on numerous factors, particularly
the use of proceeds and the return generated on those proceeds, and cannot be determined at this time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The issuance of substantial numbers of shares of common stock or
securities convertible into shares of common stock, or the perception that those issuances might occur, could materially adversely affect
us, including the per share trading price of shares of our common stock, and could be dilutive to our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The vesting of equity awards granted to certain directors, executive
officers and other employees under our equity incentive plans, the issuance of our common stock or securities convertible into shares
of our common stock in connection with future property or business acquisitions, and other issuances of our common stock could have an
adverse effect on the per share trading price of our common stock, and may adversely affect the terms upon which we may be able to obtain
additional capital through the sale of equity securities. Any particular forward sale agreement will be physically settled, unless we
elect cash or net share settlement under such forward sale agreement. If we decide to physically or net share settle any particular forward
sale agreement, delivery of shares of our common stock on any physical or net share settlement of such forward sale agreement will result
in dilution to our earnings per share and return on equity. In addition, future issuances of shares of our common stock may be dilutive
to our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B><I>The market price of our common stock is uncertain and may
fluctuate significantly, and you could lose all or part of your investment. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Volatility in the market price and trading volume of our common
stock may prevent you from being able to sell your shares at or above the price you paid for them. We cannot predict whether the market
price of our common stock will rise or fall. Numerous factors influence the trading price of our common stock. These factors may include
changes in our financial condition, results of operations and prospects, legal and administrative proceedings, and political, economic,
financial, and other global and national factors that can affect the capital markets generally, the stock exchanges on which our common
stock is traded, and our business segments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B><I>Our board of directors has the power to issue series of preferred
stock and to designate the rights and preferences of those series, which could adversely affect the voting, dividend, liquidation and
other rights of holders of our common stock.</I></B></P>


<!-- Field: Page; Sequence: 11; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Under our amended and restated certificate of incorporation, as
amended to date, our board of directors has the power to issue series of preferred stock and to designate the rights and preferences of
those series. Therefore, our board of directors may designate a new series of preferred stock with the rights, preferences and privileges
that the board of directors deems appropriate, including special dividend, liquidation and voting rights. The creation and designation
of a new series of preferred stock could adversely affect the voting, dividend, liquidation and other rights of holders of our common
stock and, possibly, any other class or series of stock that is then in existence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B><I>Our charter documents and Delaware law contain provisions
that could delay or prevent an acquisition of the Company, which could inhibit your ability to receive a premium on your investment from
a possible sale of the Company.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Our charter documents contain provisions that may discourage third
parties from seeking to acquire the Company. These provisions and specific provisions of Delaware law relating to business combinations
with interested shareholders may have the effect of delaying, deterring or preventing a merger or change in control of the Company. Some
of these provisions may discourage a future acquisition of the Company even if shareholders would receive an attractive value for their
shares or if a significant number of the our stockholders believed such a proposed transaction to be in their best interests. As a result,
stockholders who desire to participate in such a transaction may not have the opportunity to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B><I>Management will have broad discretion with respect to the
use of the proceeds of this offering.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Although we have highlighted the intended use of proceeds for this
offering, management will have broad discretion as to the application of these net proceeds and could use them for purposes other than
those contemplated at the time of this offering. Accordingly, you will be relying on the judgment of management with regard to the use
of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the net proceeds
are being used appropriately. It is possible that the net proceeds will be invested in a way that does not yield a favorable, or any,
return for the Company and cause the price of our common stock to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&thinsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="a_006" TITLE="USE OF PROCEEDS"></A>USE OF PROCEEDS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We intend to use the net proceeds that we receive upon the issuance
and sale of shares of our common stock for general corporate purposes, which may include repayment or refinancing of debt, acquisitions,
working capital, capital expenditures, and repurchases or redemptions of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The forward counterparties (or their respective affiliates) will
receive the net proceeds of any sale of borrowed shares of our common stock pursuant to this prospectus supplement in connection with
any forward sale agreement. Because (i) certain sales agents or their affiliates are expected to receive part of the net proceeds from
the sale of shares of our common stock in connection with any forward sale agreement, and (ii) some of the net proceeds of this offering
or upon settlement of any forward sale agreement may be used to repay debt, which may include amounts outstanding under our or our subsidiaries&#8217;
revolving credit facilities, in which case such sales agents may be deemed to have a conflict of interest under Rule 5121 of the Financial
Industry Regulatory Authority (&#8220;FINRA&#8221;) to the extent such sales agents or affiliates receive at least 5% of the net proceeds
of the offering. Any sales agent deemed to have a conflict of interest would be required to conduct the distribution of our common stock
in accordance with FINRA Rule 5121. If the offering is conducted in accordance with FINRA Rule 5121, such sales agent would not be permitted
to confirm a sale to an account over which it exercises discretionary authority without first receiving specific written approval from
the account holder. See &#8220;Plan of Distribution (Conflict of Interest)&#8221; for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We will not initially receive any proceeds from the sale of borrowed
shares of our common stock by the forward counterparties (or their related sales agents, as applicable) as a hedge in connection with
any forward sale agreement. The relevant forward counterparties (or their respective affiliates) will receive the net proceeds of any
sale of borrowed shares of our common stock sold pursuant to this prospectus supplement in connection with any forward sale agreement.
We currently expect to elect full physical settlement of any relevant forward sale agreement and to use the net proceeds, if any, that
we would receive upon settlement of the forward sale agreement for general corporate purposes, which may include capital expenditures
and the repayment of indebtedness. If we elect to cash settle all or a portion of any forward sale agreement, we will not receive any
proceeds from the sale of shares of our common stock related to such election of cash settlement of such forward sale agreement and we
may either receive a cash payment from, or owe a cash payment to, the forward counterparty. If we elect to net share settle all or a portion
of any relevant forward sale agreement, we will not receive any proceeds from the sale of shares of our common stock related to such election,
and we may either receive shares of our common stock from, or owe shares of our common stock to, the forward counterparty. See &#8220;Plan
of Distribution (Conflicts of Interest).&#8221;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 12pt 0 0">&thinsp;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&thinsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="a_007" TITLE="MATERIAL U.S. FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS FOR NON-U.S."></A>MATERIAL U.S. FEDERAL INCOME AND ESTATE
TAX CONSIDERATIONS FOR NON-U.S. <BR>
HOLDERS&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The following discussion summarizes material U.S. federal income
and estate tax considerations of the acquisition, ownership, and disposition of shares of our common stock that are relevant for Non-U.S.
Holders (as defined below), and does not purport to be a complete analysis of all potential U.S. federal income and estate tax considerations.
This discussion only applies to shares of our common stock that are held as capital assets, within the meaning of Section 1221 of the
Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), by Non-U.S. Holders. This summary is based on the Code, administrative
pronouncements, judicial decisions and regulations of the Treasury Department, changes to any of which subsequent to the date of this
prospectus supplement may affect the tax consequences described herein (possibly with retroactive effect). This discussion does not describe
all of the U.S. federal income or estate tax considerations that may be relevant to Non-U.S. Holders in light of their particular circumstances
or to Non-U.S. Holders subject to special rules, such as banks or certain other financial institutions, tax-exempt organizations, insurance
companies, brokers, traders or dealers in securities, persons holding shares of our common stock as part of a straddle, hedge, conversion
transaction, or other integrated or risk-reduction transaction, shareholders that acquired our common stock through the exercise of employee
stock options or otherwise as compensation or through a tax-qualified retirement plan, persons that directly, indirectly, or constructively
hold in excess of 5% of our common stock, &#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221;
governmental organizations, qualified foreign pension funds (or any entities all of the interests of which are held by a qualified foreign
pension fund), persons subject to alternative minimum tax, accrual method taxpayers subject to special tax accounting rules as a result
of their use of financial statements, persons deemed to sell our common stock under the constructive sale provisions of the Code, or certain
former citizens or residents of the United States. This discussion does not address any U.S. federal income or estate tax consequences
for any beneficial owner of shares of our common stock who is a United States person within the meaning of Section 7701(a)(30) of the
Code (a &#8220;United States person&#8221;) or any entity or arrangement treated as a partnership for U.S. federal income tax purposes.
Furthermore, this discussion does not describe the effect of U.S. federal estate (except to the limited extent set forth below), generation-skipping,
or gift tax laws, the Medicare tax on investment income, or the effect of any applicable state, local, or non-U.S. laws. Persons considering
the purchase of shares of our common stock are urged to consult their tax advisors with regard to the application of the U.S. federal
income and estate tax laws to their particular situations as well as any tax consequences arising under the laws of any state, local,
or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We have not and will not seek any rulings or opinions from the Internal
Revenue Service (the &#8220;IRS&#8221;) with respect to the matters discussed below. There can be no assurance that the IRS will not take
a different position concerning the tax consequences of the acquisition, ownership, or disposition of shares of our common stock or that
any such position would not be sustained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Prospective investors should consult their own tax advisors with
regard to the application of the U.S. federal income tax considerations discussed below to their particular situations as well as the
application of any state, local, non-U.S., or other tax laws, including gift and estate tax laws. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">For purposes of this summary, a &#8220;Non-U.S. Holder&#8221; means
a beneficial owner of shares of our common stock that, for U.S. federal income tax purposes, is: (i) a foreign corporation or any other
foreign organization classified as a corporation for U.S. federal income tax purposes, (ii) a nonresident alien individual, or (iii) a
foreign estate or trust that in either case is not subject to U.S. federal income tax on a net-income basis on income from, or gain on
sale of, a share of common stock. A prospective investor that is an individual may be deemed to be a resident alien, rather than a nonresident
alien, by virtue of being present in the United States for at least 31 days in the calendar year and for an aggregate of at least 183
days during a three-year period ending with the current calendar year. For these purposes, all the days present in the current year, one-third
of the days present in the immediately preceding year, and one-sixth of the days present in the second preceding year are counted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">If a partnership, or other entity or arrangement treated as a partnership
for U.S. federal income tax purposes, holds shares of our common stock, the tax treatment of a partner in such a partnership generally
will depend upon the status of the partner and the activities of the partnership. Partners in a partnership holding shares of our common
stock should consult their tax advisors as to the particular U.S. federal income and estate tax considerations relevant to the acquisition,
ownership, and disposition of such shares of our common stock applicable to them.</P>


<!-- Field: Page; Sequence: 14; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Distributions </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">In general, a distribution that we make to a Non-U.S. Holder with
respect to shares of our common stock will constitute a dividend for U.S. federal income tax purposes to the extent paid out of our current
or accumulated earnings and profits as determined under the Code. To the extent the amount of a distribution exceeds our current and accumulated
earnings and profits, such excess will constitute a return of capital and will first reduce the Non-U.S. Holder&#8217;s adjusted tax basis
in our common stock, but not below zero, and then will be treated as gain from the sale of our common stock (see &#8220;&#8212;Sale or
Other Taxable Disposition of Our Common Stock&#8221; below). Subject to the discussions below under &#8220;&#8212;Information Reporting
and Backup Withholding&#8221; and &#8220;&#8212;Foreign Account Tax Compliance Act,&#8221; dividends paid to a Non-U.S. Holder that are
not effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States, or not attributable
to a permanent establishment maintained by such Non-U.S. Holder within the United States under an applicable income tax treaty, generally
will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends (unless such dividend is eligible
for a reduced rate under an applicable income tax treaty). In order to obtain a reduced rate of withholding, a Non-U.S. Holder generally
is required to provide to the applicable withholding agent an IRS Form W-8BEN, IRS Form W-8BEN-E, or another appropriate version of IRS
Form W-8 (or a suitable substitute form) properly certifying such Non-U.S. Holder&#8217;s eligibility for the reduced rate. Non-U.S. Holders
that do not timely provide the applicable withholding agent with the required certification, but that qualify for a reduced withholding
rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for a refund with the IRS. Non-U.S. Holders
considering the purchase of shares of our common stock are urged to consult their tax advisors regarding their entitlement to any benefits
under an applicable income tax treaty and the timing and manner of claiming the benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Subject to the discussions below under &#8220;&#8212;Information
Reporting and Backup Withholding&#8221; and &#8220;&#8212;Foreign Account Tax Compliance Act,&#8221; dividends that are effectively connected
with a Non-U.S. Holder&#8217;s conduct of a trade or business in the United States and, if an applicable income tax treaty so requires,
are attributable to a permanent establishment maintained by the Non-U.S. Holder in the United States are taxed on a net-income basis at
the regular graduated rates applicable to United States persons. Such dividends will be exempt from the 30% U.S. federal withholding tax
if the Non-U.S. Holder provides to the applicable withholding agent a properly executed IRS Form W-8ECI (or a suitable substitute form).
In addition, a &#8220;branch profits tax&#8221; may be imposed at a 30% rate (or a reduced rate under an applicable income tax treaty)
on a foreign corporation&#8217;s effectively connected earnings and profits for the taxable year, as adjusted for certain items.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Sale or Other Taxable Disposition of Our Common Stock </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Subject to the discussions below under &#8220; &#8212;Information
Reporting and Backup Withholding&#8221; and &#8220; &#8212;Foreign Account Tax Compliance Act,&#8221; a Non-U.S. Holder generally will
not be subject to U.S. federal income tax with respect to gain, if any, recognized on the sale or other taxable disposition of shares
of our common stock, unless (i) the gain is effectively connected with the conduct by such Non-U.S. Holder of a trade or business within
the United States, and, if required by an applicable income tax treaty, is attributable to a permanent establishment maintained by such
Non-U.S. Holder within the United States, (ii) in the case of a Non-U.S. Holder that is an individual, such Non-U.S. Holder is present
in the United States for 183 or more days in the taxable year of the disposition and certain other conditions are satisfied, or (iii)
our common stock constitutes a U.S. real property interest by reason of our status as a U.S. real property holding corporation (a &#8220;USRPHC&#8221;)
for U.S. federal income tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">In the case described in (i) above, gain recognized on the disposition
of shares of our common stock generally will be subject to U.S. federal income taxation in the same manner as if such gain were recognized
by a United States person, and, in the case of a Non-U.S. Holder that is a foreign corporation, may also be subject to the branch profits
tax at a rate of 30% (or a lower applicable treaty branch profits tax rate). In the case described in (ii) above, the Non-U.S. Holder
will be subject to a 30% tax (or a lower applicable income tax treaty rate) on any capital gain recognized on the disposition of shares
of our common stock (after being offset by certain U.S.-source capital losses).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We have not made an assessment of whether we are a USRPHC; however,
even if we are a USRPHC, so long as shares of our common stock continue to be regularly traded on an established securities market in
the United States, within the meaning of applicable Treasury regulations, a Non-U.S. Holder will not be subject to U.S. federal income</P>


<!-- Field: Page; Sequence: 15; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">tax on the disposition of shares of our common stock if the Non-U.S.
Holder has not held more than 5% (directly, indirectly or constructively) of our total outstanding common stock at any time during the
shorter of the five-year period preceding the date of disposition, or such Non-U.S. Holder&#8217;s holding period. If we are a USRPHC
and our common stock were not considered to be regularly traded on an established securities market in the United States, such Non-U.S.
Holder (regardless of the percentage of shares of our common stock owned) would be subject to U.S. federal income tax on a taxable disposition
of shares of our common stock at the regular graduated rates applicable to United States persons and a 15% withholding tax would apply
to the gross proceeds from such disposition. Non-U.S. Holders considering the purchase of shares of our common stock are urged to consult
their tax advisors regarding the application of these rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Information Reporting and Backup Withholding </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Payors must report annually to the IRS and to each Non-U.S. Holder
the amount of any distributions paid to such holder, whether or not the distribution represents a taxable dividend, the name and address
of the recipient and any tax withheld with respect to such distributions, regardless of whether withholding was required. Copies of the
information returns reporting such dividends and withholding also may be made available to the tax authorities in the country in which
the Non-U.S. Holder resides under the provisions of an applicable tax treaty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">A Non-U.S. Holder may be subject to backup withholding for dividends
paid to such holder unless such holder certifies on IRS Form W-8BEN, IRS Form W-8BEN-E, or another appropriate version of IRS Form W-8
(or a suitable substitute form) that it is a Non-U.S. Holder (and the payor does not have actual knowledge or reason to know that such
holder is a United States person), or such holder otherwise establishes an exemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Information reporting and, depending on the circumstances, backup
withholding may apply to the proceeds of a sale of our common stock by a Non-U.S. Holder within the United States or conducted through
certain U.S.-related financial intermediaries, unless the beneficial owner certifies on IRS Form W-8BEN, IRS Form W-8BEN-E, or another
appropriate version of IRS Form W-8 (or a suitable substitute form) that it is a Non-U.S. Holder (and the withholding agent does not have
actual knowledge or reason to know that the beneficial owner is a United States person), or such owner otherwise establishes an exemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Backup withholding is not an additional tax. Any amounts withheld
under the backup withholding rules may be allowed as a refund or a credit against a Non-U.S. Holder&#8217;s U.S. federal income tax liability
provided the required information is timely furnished to the IRS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Foreign Account Tax Compliance Act </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Sections 1471 to 1474 of the Code and related IRS guidance (commonly
referred to as the Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;)) impose a 30% U.S. withholding tax on any dividends on our
common stock and (subject to proposed Treasury regulations discussed below) on the gross proceeds from a disposition of our common stock,
in each case, if paid to a &#8220;foreign financial institution&#8221; or a &#8220;non-financial foreign entity&#8221; (including, in
some cases, when such foreign financial institution or entity is acting as an intermediary), unless (i) in the case of a foreign financial
institution, such institution enters into an agreement with the U.S. government to withhold on certain payments, and to collect and provide
to the U.S. tax authorities substantial information regarding U.S. account holders of such institution (which includes certain equity
and debt holders of such institution, as well as certain account holders that are foreign entities with U.S. owners), (ii) in the case
of a non-financial foreign entity, such entity certifies that it does not have any substantial U.S. owners or provides the withholding
agent with a certification (generally on IRS Form W-8BEN-E) identifying the direct and indirect substantial U.S. owners of the entity,
or (iii) the foreign financial institution or non-financial foreign entity otherwise qualifies for an exemption from these rules and
provides appropriate documentation (such as an IRS Form W-8BEN-E). If a dividend payment is both subject to withholding under FATCA and
subject to the withholding tax discussed above under &#8220;&#8212; Distributions,&#8221; an applicable withholding agent may credit
the withholding under FATCA against, and therefore reduce, such other withholding tax. Although withholding under FATCA would have applied
to payments of gross proceeds from the taxable disposition of our common stock on or after January 1, 2019, proposed Treasury regulations
eliminate FATCA withholding on payments of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury regulations
until final Treasury regulations are issued. Intergovernmental agreements governing FATCA between the United States and certain other
countries may modify the foregoing requirements for certain holders of our common stock. Prospective investors should consult their own
tax advisors regarding FATCA and whether it may be relevant to the ownership and disposition of shares of our common stock.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>


<!-- Field: Page; Sequence: 16; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Federal Estate Tax </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Shares of our common stock beneficially owned by an individual who
is not a citizen or resident of the United States (as defined for U.S. federal estate tax purposes) at the time of death generally will
be includable in the decedent&#8217;s gross estate for U.S. federal estate tax purposes unless an applicable income tax treaty provides
otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>The preceding discussion of material U.S. federal income and
estate tax considerations is for general information only. It is not tax advice. Prospective investors should consult their own tax advisors
regarding the particular U.S. federal, state and local and non-U.S. tax consequences of acquiring, owning and disposing of our common
stock, including the consequences of any proposed changes in applicable laws.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 17; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>&thinsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="a_008" TITLE="PLAN OF DISTRIBUTION (CONFLICTS OF INTEREST)"></A>PLAN OF DISTRIBUTION (CONFLICTS OF INTEREST)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We entered into an equity distribution agreement on August 7, 2025
with each of the sales agents and forward counterparties. Under the terms of the equity distribution agreement we may issue and sell from
time to time during the term of such agreement shares of our common stock having an aggregate gross sales price of up to $400,000,000
through the sales agents acting as our agents. Under the equity distribution agreement, we may also sell shares of our common stock to
the applicable sales agent, as principal for its own account, at a price to be agreed upon at the time of sale. If we sell our shares
of common stock to either sales agent, as principal for its own account, we will enter into a separate terms agreement with such sales
agent, and we will describe such agreement in a separate prospectus supplement or pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Further, the equity distribution agreement provides that, in addition
to the issuance and sale of shares of our common stock by us through the applicable sales agent, we may request that such sales agent,
as or on behalf of a forward counterparty, use commercially reasonable efforts to sell, from time to time, shares of our common stock
borrowed by the applicable forward counterparty (or its affiliates) in connection with one or more forward sale agreements as described
below. In no event will the aggregate number of shares of our common stock sold through the sales agents, each as an agent for us and
as or on behalf of a forward counterparty, under the equity distribution agreement have an aggregate gross sales price in excess of $400,000,000.
We entered into master forward sale confirmations with each of the forward counterparties on August 7, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The shares of our common stock to which this prospectus supplement
relates may be offered and sold by any method permitted by law to be an &#8220;at the market offering&#8221; as defined in Rule 415 under
the Securities Act, including by means of ordinary brokers&#8217; transactions on the NYSE, the existing trading market for our shares
of common stock, or sales made to or through a market maker or through an electronic communications network. In addition, shares of our
common stock may be offered and sold by such other methods, including privately negotiated transactions (including block trades), as we
and any sales agent agree to in writing. The sales agents are not required to sell any specific number or dollar amount of shares of our
common stock, but each of them and the forward counterparty, as applicable, will use its commercially reasonable efforts to sell shares
designated by us in accordance with the equity distribution agreement. Neither we nor the sales agents will engage in any transactions
that stabilize our common stock. There is no arrangement for funds to be received in an escrow, trust, or similar arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We estimate that the total initial expenses for the offering, excluding
compensation payable under the equity distribution agreement, will be approximately $550,000, and we expect to incur additional expenses
(in addition to any such commissions and expense reimbursement) in the future. We have agreed to reimburse the sales agents for certain
reasonable documented out-of-pocket expenses, including the reasonable fees, disbursements and expenses of their counsel, in the amount
of up to $75,000 in connection with entering into the equity distribution agreement and performing their obligations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">In connection with the sale of our common stock as contemplated
in this prospectus supplement, the sales agents may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act,
and the compensation paid to a sales agent may be deemed to be underwriting commissions or discounts. We have agreed to indemnify the
sales agents and the forward counterparties against certain liabilities, including liabilities under the Securities Act, or to contribute
to payments which they may be required to make in that respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We intend to report to the SEC at least quarterly (1) the number
of shares of our common stock sold through the sales agents in connection with at-the-market sales as described below under &#8220;&#8212;Sales
Through Sales Agents,&#8221; (2) the number of borrowed shares of our common stock sold by the forward counterparties in connection with
forward sale agreements as described below under &#8220;&#8212;Sales Through Forward Counterparties&#8221; and (3) the net proceeds received
by us and the compensation paid by us to the sales agents in connection with transactions described in clauses (1) and (2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Sales of our common stock as contemplated in this prospectus supplement
will be settled through the facilities of The Depository Trust Company or by such other means as may be agreed upon. The offering of
our common stock pursuant to the equity distribution agreement will terminate upon the earliest of (1) the sale, under the equity distribution
agreement, of shares of our common stock with an aggregate gross sales price equal to $400,000,000 and (2) the termination of the equity
distribution agreement, pursuant to its terms, by us, the sales agents (with respect to each of their own rights and obligations thereunder),
or the forward counterparties (with respect to each of their own rights and obligations thereunder).</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>


<!-- Field: Page; Sequence: 18; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Sales Through Sales Agents as our Sales Agents or to Sales Agents
as Principals</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">From time to time during the term of the equity distribution agreement,
and subject to the terms and conditions set forth therein, we may deliver instructions to any of the sales agents regarding a proposed
sale of shares of our common stock. We will submit orders to only one sales agent relating to the sale of shares of the common stock on
any given day. Upon receipt of instructions from us, and subject to the terms and conditions of the equity distribution agreement, the
applicable sales agent will use its commercially reasonable efforts, consistent with its normal trading and sales practices, to sell the
amount of shares of our common stock specified in our instructions. Pursuant to the equity distribution agreement, each sales agent will
provide written confirmation to us no later than the opening of trading on the NYSE on the business day immediately following each day
on which shares of our common stock are sold by such sales agent for us under the equity distribution agreement. Each confirmation will
include the number of shares sold on that day, the gross sales price per share and the net sales price per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We or the relevant sales agent may suspend the offering of shares
of our common stock at any time upon proper notice to the other party, at which time the selling period will immediately terminate. Settlement
for sales of shares of our common stock will occur on the first trading day following the date on which the sales were made (or such other
day as may, from time to time, become standard industry practice). The obligation of the applicable sales agent under the equity distribution
agreement to sell shares of our common stock pursuant to our instructions is subject to a number of conditions, which each sales agent
reserves the right to waive in its sole discretion. There is no arrangement for funds to be received in an escrow, trust, or similar arrangement.
Under the equity distribution agreement, we may also sell shares of our common stock to the applicable sales agent, as principal for its
own account, at a price to be agreed upon at the time of sale. If we sell our shares of common stock to either sales agent, as principal
for its own account, we will enter into a separate terms agreement with such sales agent, and we will describe such agreement in a separate
prospectus supplement or pricing supplement. In addition, shares of our common stock may be offered and sold by such other methods, including
privately negotiated transactions (including block trades), as we and any sales agent agree to in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Each sales agent will receive from us a commission of up to 1.0%
of the gross sales price per share for any shares sold through it as our sales agent under the equity distribution agreement. The commission
we pay to any sales agent for sales by privately negotiated transactions (including block trades) or other methods may vary, as we and
any sales agent agree to in writing. The remaining sales proceeds, after deducting any expenses payable by us and any transaction fees
imposed by any governmental, regulatory, or self-regulatory organization in connection with the sales, will be our net proceeds for the
sale of such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Sales Through Forward Counterparties </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">From time to time during the term of the equity distribution agreement,
and subject to the terms and conditions set forth therein, we may enter into one or more forward sale agreements with the applicable forward
counterparty. In connection with each such forward sale agreement, we will deliver to the applicable forward counterparty related instructions
requesting that the applicable forward counterparty (or its related sales agent, as applicable) execute sales of borrowed shares of our
common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Upon their receipt and acceptance, such forward counterparty (or
its affiliates) will attempt to borrow, and such forward counterparty (or its related sales agent, as applicable) will use commercially
reasonable efforts to sell, the relevant shares of our common stock to hedge such forward counterparty&#8217;s exposure under that particular
forward sale agreement. We or such forward counterparty may immediately suspend the offering of our common stock at any time upon proper
notice to the other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">In no event will we be party to outstanding forward sale agreements
with more than one forward counterparty at any given time or party to more than one forward sale agreement with the same forward counterparty
at any given time unless such forward counterparties (or their related sales agents, as applicable) would not be selling shares of our
common stock simultaneously, and such forward counterparties would not be required to unwind their respective hedges of shares of our
common stock at any time that such forward counterparties (or their related sales agents, as applicable) are selling shares of our common
stock. Additionally, in no event may we sell shares directly at any given time when we are a party to outstanding forward sale agreements
unless the related forward counterparties (or their related sales agents, as applicable) would not then be selling shares of our common
stock and such forward counterparties would not then be required to unwind their respective hedges of shares of our common stock.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>


<!-- Field: Page; Sequence: 19; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We expect that such settlement will generally occur on the first
trading day following each date such sales are made, unless another date shall be agreed to by the relevant parties. The obligation of
the relevant forward counterparty (or its related sales agent, as applicable) under the equity distribution agreement to execute such
sales of our common stock is subject to a number of conditions, which each forward counterparty (or its related sales agent, as applicable)
reserves the right to waive in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">In connection with each forward sale agreement, the relevant forward
counterparty will receive, reflected in a reduced initial forward sale price payable by the relevant forward counterparty under its forward
sale agreement, a commission of up to 1.0% of the volume weighted average of the sales prices of all borrowed shares of our common stock
sold during the applicable period by it as a forward counterparty (or its related sales agent, as applicable). We refer to this commission
rate as the forward selling commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The forward sale price per share under each forward sale agreement
will initially equal the product of (1) an amount equal to one minus the applicable forward selling commission and (2) the volume-weighted
average price per share at which the borrowed shares of our common stock were sold pursuant to the equity distribution agreement by the
relevant forward counterparty (or its related sales agent, as applicable). Thereafter, the forward sale price will be subject to adjustment
as described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The forward sale agreements provide that the forward sale price,
as well as the sales prices used to calculate the initial forward sale price, will be subject to increase or decrease based on an
interest rate factor equal to the specified benchmark&#8217;s daily rate less a spread and subject to decrease by amounts related to expected
dividends on our common stock during the term of the particular forward sale agreement. If the specified benchmark&#8217;s daily rate
is less than the spread for a particular forward sale agreement on any day, the interest factor will result in a reduction of the applicable
forward sale price for such day. If the specified benchmark&#8217;s daily rate decreases below the spread for a particular forward sale
agreement and does not subsequently increase above such spread, we may receive less than the initial forward sale price per share upon
physical settlement of that particular forward sale agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Before settlement of a particular forward sale agreement, we expect
that the shares of our common stock issuable upon settlement of that particular forward sale agreement will be reflected in our diluted
earnings per share using the treasury stock method. Under this method, the number of shares of our common stock used in calculating diluted
earnings per share is deemed to be increased by the excess, if any, of the number of shares of our common stock that would be issued upon
full physical settlement of that particular forward sale agreement over the number of shares of our common stock that could be purchased
by us in the market (based on the average market price of our common stock during the relevant period) using the proceeds receivable upon
full physical settlement (based on the adjusted forward sale price at the end of the relevant reporting period). Consequently, before
physical or net share settlement of a particular forward sale agreement and subject to the occurrence of certain events, we anticipate
there will be no dilutive effect on our earnings per share, except during periods when the average market price of our common stock is
above the applicable adjusted forward sale price. However, if we decide to physically or net share settle any forward sale agreement,
any delivery of shares of our common stock by us upon any physical or net share settlement of such forward sale agreement will result
in dilution to our earnings per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Except under limited circumstances, we have the right to elect physical,
cash, or net share settlement under any forward sale agreement. Although we expect to settle any forward sale agreement entirely by delivering
shares of our common stock in connection with full physical settlement, we may, subject to certain conditions, elect cash settlement or
net share settlement for all or a portion of our obligations under a particular forward sale agreement if we conclude that it is in our
interest to do so. For example, we may conclude that it is in our interest to cash settle or net share settle a particular forward sale
agreement if we have no then-current use for all or a portion of the net proceeds that we would receive upon physical settlement. In addition,
subject to certain conditions, we may elect to accelerate the settlement of all or a portion of the number of shares of our common stock
underlying a particular forward sale agreement.</P>


<!-- Field: Page; Sequence: 20; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">If we elect to physically settle any forward sale agreement by issuing
and delivering shares of our common stock, we will receive an amount of cash from the relevant forward counterparty equal to the product
of the forward sale price per share under that particular forward sale agreement and the number of shares of our common stock underlying
the particular forward sale agreement. In the event that we elect to cash settle, the settlement amount will be generally related to (1)
(a) the average of the volume-weighted average price of our common stock on each exchange business day during the relevant valuation period
under the particular forward sale agreement minus (b) the applicable forward sale price; multiplied by (2) the number of shares of our
common stock underlying the particular forward sale agreement subject to cash settlement. In the event we elect to net share settle, the
settlement amount will be generally related to (1) (a) the weighted average price at which the relevant forward counterparty or its affiliate
purchases shares of our common stock during the relevant valuation period for such settlement under that particular forward sale agreement
minus (b) the applicable forward sale price; multiplied by (2) the number of shares of our common stock underlying the particular forward
sale agreement subject to such net share settlement. If this settlement amount is a negative number, the relevant forward counterparty
will pay us the absolute value of that amount (in the case of cash settlement) or deliver to us a number of shares of our common stock
having a value equal to the absolute value of such amount (in the event of net share settlement). If this settlement amount is a positive
number, we will pay the relevant forward counterparty that amount (in the case of cash settlement) or deliver to the relevant forward
counterparty a number of shares of our common stock having a value equal to such amount (in the event of net share settlement). In connection
with any cash settlement or net share settlement, we would expect the relevant forward counterparty or its affiliate to purchase shares
of our common stock in secondary market transactions for delivery to third-party stock lenders to close out its, or its affiliate&#8217;s,
hedge position in respect of that particular forward sale agreement. The purchase of shares of our common stock in connection with the
relevant forward counterparty or its affiliate unwinding its hedge positions could cause the price of our common stock to increase (or
prevent a decrease), thereby increasing the amount of cash we would owe to the relevant forward counterparty (or decreasing the amount
of cash that the relevant forward counterparty would owe us) upon cash settlement or increasing the number of shares of our common stock
that we are obligated to deliver to the relevant forward counterparty (or decreasing the number of shares of our common stock that the
relevant forward counterparty is obligated to deliver to us) upon net share settlement of the particular forward sale agreement. See &#8220;Risk
Factors.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">With respect to any forward sale agreement we may enter into, the
relevant forward counterparty will have the right to accelerate settlement of such forward sale agreement and require us to physically
settle or, if we so elect and the forward counterparty permits our election, cash settle, or net share settle on a date specified by the
relevant forward counterparty if:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">in the good faith, commercially reasonable judgment of the forward counterparty, it, or its affiliate
is unable to hedge its exposure to the transactions contemplated by its forward sale agreement because of the lack of sufficient shares
of our common stock being made available for borrowing by stock lenders or it, or its affiliate, is unable to borrow such number of shares
at a rate equal to or less than an agreed maximum stock loan rate;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">we declare any dividend or distribution on shares of our common stock payable in (i) cash in excess
of a specified amount (other than an extraordinary dividend), (ii) securities of another company, or (iii) any other type of securities
(other than our common stock), rights, warrants, or other assets for payment (cash or other consideration) at less than the prevailing
market price, as reasonably determined by the forward counterparty;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">certain ownership thresholds applicable to the forward counterparty are exceeded;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">an event is announced that, if consummated, would result in an extraordinary event (as defined in the
forward sale agreement) including, among other things, certain mergers and tender offers, as well as certain events such as a delisting
of our common stock (each as more fully described in the forward sale agreement); or</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">certain other events of default or termination events occur, including, among other things, any material
misrepresentation made by us in connection with our entry into the forward sale agreement, our bankruptcy</FONT></TD></TR></TABLE>


<!-- Field: Page; Sequence: 21; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">(except as described below), or certain changes in law (each
as more fully described in the forward sale agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">A forward counterparty&#8217;s decision to exercise its right to
accelerate settlement of a particular forward sale agreement (or, in certain cases, the portion thereof that it determines is affected
by the relevant event) and to require us to settle such forward sale agreement will be made irrespective of our interests, including our
need for capital. In such cases, we could be required to issue and deliver shares of our common stock under the terms of the physical
settlement provisions of the forward sale agreement irrespective of our capital needs, which would result in dilution to our earnings
per share and may adversely affect the market price of our common stock. In addition, upon certain events of bankruptcy or insolvency
relating to us, the forward sale agreement will automatically terminate without further liability of either party to the agreement. Following
any such termination, we would not issue any shares of our common stock and we would not receive any proceeds pursuant to the forward
sale agreement. See &#8220;Risk Factors.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>No Public Offering Outside of the United States </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">No action has been or will be taken in any jurisdiction (except
in the United States) that would permit a public offering of the shares of our common stock, or the possession, circulation, or distribution
of this prospectus supplement or the accompanying prospectus or any other material relating to us or the shares of our common stock, in
any jurisdiction where action for that purpose is required. Accordingly, the shares of our common stock offered by this prospectus supplement
and the accompanying prospectus may not be offered or sold, directly or indirectly, and this prospectus supplement, the accompanying prospectus
and any other offering material or advertisements in connection with the shares of our common stock may not be distributed or published,
in or from any country or jurisdiction except in compliance with any applicable rules and regulations of any such country or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Certain Relationships </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Each sales agent, each forward counterparty, and their respective
affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and
investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing, and brokerage
activities. Each sales agent, each forward counterparty, and their respective affiliates have acted and/or are acting as lenders to, and/or
have from time to time performed and/or are performing, and may in the future engage in, certain investment banking, advisory, general
financing, commercial banking, and other commercial transactions and services in the ordinary course of business with us or our affiliates
for which they have received and, in the future, may receive customary fees and expenses. For instance, an affiliate of Wells Fargo serves
as joint-lead arranger, and an affiliate of BofA Securities serves as lender under our $200 million revolving credit facility, Cascade
Natural Gas Corporation&#8217;s (&#8220;Cascade&#8221;) $175 revolving credit facility and Intermountain Gas Corporation&#8217;s (&#8220;Intermountain&#8221;)
$175 million revolving credit facility. An affiliate of Wells Fargo serves as joint-lead arranger and joint-lead bookrunner and its affiliate
serves as administrative agent, swingline lender and lender, and an affiliate of BofA Securities serves as lender under Montana-Dakota&#8217;s
$200 million revolving credit facility. The sales agents and their affiliates may, from time to time, engage in other transactions with
or perform other services for us and our affiliates in the ordinary course of their business for which they receive customary fees and
expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">In addition, in the ordinary course of their various business activities,
the sales agents, forward counterparties and their respective affiliates, officers, directors, and employees may purchase, sell, or hold
a broad array of investments and actively trade securities, derivatives, loans, commodities, currencies, credit default swaps, and other
financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment and trading
activities may involve or relate to assets, securities, or instruments of ours (directly, as collateral securing other obligations or
otherwise) or persons and entities with relationships with us. Certain of the sales agents, forward counterparties, or their respective
affiliates that have a lending relationship with us routinely hedge, and certain others of those sales agents, forward counterparties,
or their respective affiliates may hedge, their credit exposure to us consistent with their customary risk management policies. Typically,
such sales agents, forward counterparties, and their respective affiliates would hedge such exposure by entering into transactions which
consist of either the purchase of credit default swaps or the creation of short positions in our securities, including potentially the
shares offered hereby. Any such credit default swaps or short positions could adversely affect the future trading prices of the shares
offered hereby. The sales agents, forward counterparties, and their respective affiliates may also communicate independent investment
recommendations, market color, or trading ideas, or publish or express independent research views in respect of such assets, securities,
or financial instruments and may at any time hold, or recommend to clients that they should acquire, long and/or short positions in such
assets, securities, and instruments.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>


<!-- Field: Page; Sequence: 22; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Conflicts of Interest </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The forward counterparties (or their respective affiliates) will
receive the net proceeds of any sale of borrowed shares of our common stock pursuant to this prospectus supplement in connection with
any forward sale agreement. In addition, affiliates of certain of the sales agents are lenders under our revolving credit facility, Cascade&#8217;s
revolving credit facility, Intermountain&#8217;s revolving credit facility or Montana-Dakota&#8217;s revolving credit facility. To the
extent that we use the net proceeds from this offering or upon settlement of any forward sale agreement to repay amounts we have borrowed
or may borrow or re-borrow in the future under our revolving credit facility, Cascade&#8217;s revolving credit facility, Intermountain&#8217;s
revolving credit facility or Montana-Dakota&#8217;s revolving credit facility, these lenders will receive their pro rata portions of such
proceeds. Because (i) certain sales agents or their affiliates are expected to receive part of the net proceeds from the sale of shares
of our common stock in connection with any forward sale agreement, and (ii) some of the net proceeds of this offering or upon settlement
of any forward sale agreement may be used to repay amounts outstanding under our revolving credit facility, Cascade&#8217;s revolving
credit facility, Intermountain&#8217;s revolving credit facility or Montana-Dakota&#8217;s revolving credit facility, such sales agents
would be deemed to have a conflict of interest under FINRA Rule 5121 to the extent such sales agents or affiliates receive at least 5%
of the net proceeds of the offering. Any sales agent deemed to have a conflict of interest would be required to conduct the distribution
of our common stock in accordance with FINRA Rule 5121. If the offering is conducted in accordance with FINRA Rule 5121, such sales agent
would not be permitted to confirm a sale to an account over which it exercises discretionary authority without first receiving specific
written approval from the account holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 0 12pt">&thinsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="a_009" TITLE="WHERE YOU CAN FIND MORE INFORMATION"></A>WHERE YOU CAN FIND MORE INFORMATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We file annual, quarterly and current reports, proxy statements,
and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC&#8217;s website at www.sec.gov.
Information about us is also available at our website at www.mdu.com. However, the information accessible on or through our website is
not a part of this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">This prospectus supplement and the accompanying prospectus, which
include information incorporated by reference, are part of a registration statement we have filed with the SEC. As permitted by the SEC&#8217;s
rules, this prospectus supplement and the accompanying prospectus do not contain all of the information included in the registration statement
and the accompanying exhibits and schedules we file with the SEC. You should read the registration statement and the exhibits and schedules
for more complete information about us and our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The SEC allows us to incorporate by reference information into this
prospectus supplement and the accompanying prospectus, which means that we can disclose important information to you by referring you
to other documents filed separately with the SEC. The information incorporated by reference is considered to be part of this prospectus
supplement and the accompanying prospectus. We incorporate by reference the following documents that we filed with the SEC:&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">our </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000016/mdu-20241231.htm"><FONT STYLE="font-size: 10pt; color: blue">Annual
Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 20, 2025</FONT></A><FONT STYLE="font-size: 10pt">;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">the Part III information contained in our </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000031/mdu-20250402.htm"><FONT STYLE="font-size: 10pt; color: blue">definitive
proxy statement on Schedule 14A for our 2025 annual meeting of stockholders, filed with the SEC on April 3, 2025</FONT></A><FONT STYLE="font-size: 10pt">,
that was incorporated into our </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000016/mdu-20241231.htm"><FONT STYLE="font-size: 10pt; color: blue">Annual
Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 20, 2025</FONT></A><FONT STYLE="font-size: 10pt">;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">our <FONT STYLE="background-color: white">Quarterly
                                            Reports on Form&nbsp;10-Q for the quarters ended </FONT></FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000042/mdu-20250331.htm"><FONT STYLE="font-size: 10pt; background-color: white">March
                                            31, 2025</FONT></A> <FONT STYLE="font-size: 10pt; background-color: white">and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/67716/000006771625000074/mdu-20250630.htm">June 30, 2025</A>,
                                            filed with the SEC on May 8, 2025 and August 7, 2025, respectively; </FONT></TD></TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt; background-color: white">our Current
                                            Reports on Form&nbsp;8-K filed with the SEC on </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000012/mdu-20250214.htm"><FONT STYLE="font-size: 10pt; background-color: white">February
                                            14, 2025</FONT></A> <FONT STYLE="font-size: 10pt">and </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/67716/000006771625000052/mdu-20250513.htm"><FONT STYLE="font-size: 10pt; color: blue">May
                                            15, 2025</FONT></A><FONT STYLE="font-size: 10pt">; <FONT STYLE="background-color: white">and</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
  <TD STYLE="padding-left: 0pt; text-indent: 0pt">the description of our securities contained in <A HREF="https://www.sec.gov/Archives/edgar/data/67716/000110465919000026/a18-41510_6ex99db.htm#Exhibit99b_015209"><FONT STYLE="font-size: 10pt; background-color: white">Exhibit
99(b)</FONT></A> to our Current Report
  on Form 8-K12B, filed with the SEC on January 2, 2019, including any amendments or reports filed for the purpose of updating such
  description (including <A HREF="https://www.sec.gov/Archives/edgar/data/67716/000006771620000010/a2019ex4g.htm"><FONT STYLE="font-size: 10pt; background-color: white">Exhibit
4(a)</FONT></A>  to our Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on
  February 21, 2020).</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We also incorporate by reference all documents we subsequently file
pursuant to Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act, after the date of this prospectus, and before we terminate the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We are not incorporating by reference any documents or portions
of documents that are not deemed filed with the SEC, including any information furnished pursuant to Items 2.02 or 7.01 of Form 8-K.
Any statement contained in a document incorporated or deemed to be incorporated by reference in or deemed to be part of this prospectus
supplement or the accompanying prospectus shall be deemed to be modified or superseded for purposes of this prospectus supplement or
the accompanying prospectus to the extent that a statement contained in any other subsequently filed document which also is or is deemed
to be incorporated by reference or deemed to be part of this prospectus supplement or the accompanying prospectus modifies or replaces
such statement. Any statement contained in a document that is deemed to be incorporated by reference or deemed to be part of the prospectus
after the most recent effective date may modify or replace existing statements contained in this prospectus supplement or the accompanying
prospectus. Any such statement so modified or superseded shall not be deemed in its unmodified form to constitute a part of this prospectus
supplement or the accompanying prospectus for purposes of the Securities Act.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>



<!-- Field: Page; Sequence: 24; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">We will provide to each person, including any beneficial owner,
to whom this prospectus supplement and accompanying prospectus is delivered, a copy of any or all of the information that has been incorporated
by reference in this prospectus supplement and the accompanying prospectus but not delivered with this prospectus supplement and the accompanying
prospectus. You may obtain a copy of this information at no cost by written or oral request to us at the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">Office of the Treasurer<BR>
MDU Resources Group, Inc.<BR>
1200 West Century Avenue<BR>
P.O. Box 5650<BR>
Bismarck, North Dakota 58506-5650<BR>
Telephone: (701) 530-1000&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">You may also access these documents at our website at www.mdu.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">You should rely only on information contained or incorporated by
reference in this prospectus supplement and the accompanying prospectus. We have not authorized any other person to provide you with different
information. We are not making an offer to sell the securities offered hereby in any jurisdiction where the offer or sale is not permitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The information contained in or incorporated by reference in this
prospectus supplement and the accompanying prospectus is accurate only as of the date of the respective documents in which the information
is contained. Our business, financial condition, results of operations, and prospects may have changed since those dates.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="a_010" TITLE="LEGAL MATTERS"></A>LEGAL MATTERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Certain legal matters in connection with this offering, including
the validity of the common stock offered hereby, will be passed upon for us by Perkins Coie LLP. Certain legal matters in connection with
this offering will be passed upon for the sales agents, forward sellers and forward purchasers by Simpson Thacher &amp; Bartlett LLP,
Houston, Texas.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><A NAME="a_011" TITLE="EXPERTS"></A>EXPERTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">The financial statements of MDU Resources Group, Inc. as of December
31, 2024 and 2023, and for each of the three years in the period ended December 31, 2024, incorporated by reference in this prospectus
supplement, and the effectiveness of MDU Resources Group, Inc.&#8217;s internal control over financial reporting, have been audited by
Deloitte &amp; Touche LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements are
incorporated by reference in reliance upon the reports of such firm, given their authority as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;<BR STYLE="clear: both">
</P>


<!-- Field: Page; Sequence: 25; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; padding-top: 6pt; padding-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="mduresourceslogo.jpg" ALT=""></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&thinsp;</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>MDU RESOURCES GROUP, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Debt Securities </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Purchase Contracts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Units</B></FONT><B><BR>
<BR>
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We may offer from time to time any combination of
the securities described in this prospectus in one or more offerings and in amounts authorized from time to time. We will provide the
specific terms of our securities, including their offering prices, in supplements to this prospectus. The supplements may also add, update
or change information contained in this prospectus. You should read this prospectus and any supplements carefully before you invest. <FONT STYLE="background-color: white">The
securities may be sold to or through one or more underwriters, dealers or agents, or directly to investors, on a continuous or delayed
basis. See &ldquo;Plan of Distribution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our common stock is listed on the New York Stock Exchange
(the &ldquo;NYSE&rdquo;) and trades under the symbol &ldquo;MDU.&rdquo; The last reported sale price of our common stock on the NYSE on
August 6, 2025 was $17.49 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">___________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="background-color: white"><B>Investing
in our securities involves risks. See &ldquo;</B></FONT><A HREF="#a_RISK_FACTORS"><FONT STYLE="background-color: white"><B>Risk
Factors</B></FONT></A><FONT STYLE="background-color: white"><B>&rdquo; on page&thinsp;2 of this prospectus, and any applicable
prospectus supplement, and in the documents that are incorporated by reference herein.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="background-color: white"><B>Neither the
Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon
the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense</B></FONT><B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">___________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 1.5in; text-align: center">The date of this prospectus is August 7, 2025.</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%">&thinsp;</TD><TD STYLE="width: 33%">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&thinsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; margin-bottom: 1in">
  <TR>
    <TD STYLE="width: 94%; padding-top: 1.5pt"><FONT STYLE="font-size: 10pt">&thinsp;</FONT></TD>
    <TD STYLE="width: 6%; padding-top: 1.5pt; padding-right: 3pt; padding-left: 1.5pt; text-align: right"><FONT STYLE="font-size: 10pt"><U>Page</U></FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_001"><FONT STYLE="font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_001"><FONT STYLE="font-size: 10pt">i</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_002"><FONT STYLE="font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_002"><FONT STYLE="font-size: 10pt">ii</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_003"><FONT STYLE="font-size: 10pt">MDU RESOURCES GROUP, INC.</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_003"><FONT STYLE="font-size: 10pt">1</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_004"><FONT STYLE="font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_004"><FONT STYLE="font-size: 10pt">2</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_005"><FONT STYLE="font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_005"><FONT STYLE="font-size: 10pt">3</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_006"><FONT STYLE="font-size: 10pt">DESCRIPTION OF CAPITAL STOCK</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_006"><FONT STYLE="font-size: 10pt">4</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_007"><FONT STYLE="font-size: 10pt">DESCRIPTION OF DEBT SECURITIES</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_007"><FONT STYLE="font-size: 10pt">7</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_008"><FONT STYLE="font-size: 10pt">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_008"><FONT STYLE="font-size: 10pt">8</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_009"><FONT STYLE="font-size: 10pt">DESCRIPTION OF PURCHASE CONTRACTS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_009"><FONT STYLE="font-size: 10pt">9</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_010"><FONT STYLE="font-size: 10pt">DESCRIPTION OF UNITS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_010"><FONT STYLE="font-size: 10pt">10</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_011"><FONT STYLE="font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_011"><FONT STYLE="font-size: 10pt">11</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_012"><FONT STYLE="font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_012"><FONT STYLE="font-size: 10pt">13</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_013"><FONT STYLE="font-size: 10pt">INFORMATION INCORPORATED BY REFERENCE</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_013"><FONT STYLE="font-size: 10pt">13</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_014"><FONT STYLE="font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_014"><FONT STYLE="font-size: 10pt">14</FONT></A></TD></TR>
  <TR>
    <TD STYLE="padding-top: 1.5pt"><A HREF="#pr_015"><FONT STYLE="font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="vertical-align: top; padding-top: 1.5pt; padding-right: 0.75pt; padding-left: 1.5pt; text-align: right"><A HREF="#pr_015"><FONT STYLE="font-size: 10pt">14</FONT></A></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%">&thinsp;</TD><TD STYLE="width: 33%">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="pr_001"></A>ABOUT THIS PROSPECTUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">This prospectus is part of an automatic shelf registration
statement that we filed under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), with the Securities and Exchange
Commission (the &ldquo;SEC&rdquo;) utilizing an automatic &ldquo;shelf&rdquo; registration process as a &ldquo;well-known seasoned issuer&rdquo;
as defined in Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Under this shelf registration process, we may issue
and sell any combination of the securities described in this prospectus in one or more offerings from time to time. <FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">This
prospectus provides you with a general description of the securities we may offer. Each time we offer the securities described in this
prospectus, we will provide you with a prospectus supplement that will describe the specific amounts, prices and terms of the securities
being offered. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information
relating to these offerings. The prospectus supplement or free writing prospectus may also add, update or change information contained
in or incorporated by reference into this prospectus with respect to that offering. If there is any inconsistency between the information
in this prospectus and the applicable prospectus supplement or free writing prospectus, you should rely on the prospectus supplement or
free writing prospectus, as applicable. This prospectus does not contain all the information provided in the registration statement filed
with the SEC. You should carefully read both this prospectus and any applicable prospectus supplement (and any applicable free writing
prospectus) together with the additional information described below under &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Information
Incorporated By Reference&rdquo; before you make an investment decision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="background-color: white">We have not
authorized anyone to provide any information other than that contained or incorporated by reference in this prospectus or in any prospectus
supplement or free writing prospectus prepared by or on behalf of us or to which we have referred you. We take no responsibility for,
and can provide no assurance as to the reliability of, any other information that others may give you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">You
should assume that the information appearing in this prospectus and the applicable prospectus supplement to this prospectus is accurate
as of the date on its respective cover and that any information incorporated by reference is accurate only as of the date of the document
incorporated by reference, unless we indicate otherwise. Our business, financial condition, results of operations and prospects may have
changed since those dates. Any statement made in this prospectus or in a document incorporated or deemed to be incorporated by reference
in this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained
in a prospectus supplement or in any other subsequently filed document that is also incorporated or deemed to be incorporated by reference
in </FONT><FONT STYLE="background-color: white">this prospectus modifies or supersedes that statement. Any statement so modified or superseded
will not be deemed, except as so modified or superseded, to constitute a part of this prospectus. See &ldquo;Information Incorporated
By Reference.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 1in; text-indent: 0.25in">Unless the context otherwise indicates, references
in this prospectus to the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; and &ldquo;us&rdquo; refer to MDU Resources Group,
Inc. and its subsidiaries. <FONT STYLE="background-color: white">The term &ldquo;you&rdquo; refers to a prospective investor.<BR STYLE="clear: both">
</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="pr_002"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><A NAME="a_Hlk197950063"></A>This prospectus,
any related prospectus supplement and the documents that we incorporate by reference herein and therein may contain forward-looking
statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as
amended (the &ldquo;Exchange Act&rdquo;). Other than statements of historical facts, all statements which address activities,
events, or developments that the Company anticipates will or may occur in the future are based on underlying assumptions (many of
which are based, in turn, upon further assumptions), including, but not limited to, statements identified by the words
&ldquo;anticipates,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo; &ldquo;plans,&rdquo; and
&ldquo;predicts&rdquo; in each case related to such things as growth estimates, stockholder value creation, the Company&rsquo;s
&ldquo;CORE&rdquo; strategy, capital expenditures, financial guidance, trends, objectives, goals, dividend payout ratio targets,
strategies and other such matters, are forward-looking statements. These forward-looking statements are based on many assumptions
and factors, which are detailed in the Company&rsquo;s filings with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 1in; text-indent: 0.25in">While made in good faith, these forward-looking statements
are based largely on the Company&rsquo;s expectations and judgments and are subject to a number of risks and uncertainties, many of which
are unforeseeable and beyond the Company&rsquo;s control. For additional discussion regarding risks and uncertainties that may affect
forward-looking statements, see Part I, Item 1A. Risk Factors in the Company&rsquo;s <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000016/mdu-20241231.htm">Annual
Report on Form 10-K for the year ended December 31, 2024</A>, Part II, Item 1A. Risk Factors in the Company&rsquo;s <FONT STYLE="background-color: white">Quarterly
Reports on Form&thinsp;10-Q for the quarters ended </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000042/mdu-20250331.htm"><FONT STYLE="background-color: white">March
31, 2025</FONT></A> <FONT STYLE="background-color: white">and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/67716/000006771625000074/mdu-20250630.htm">June 30, 2025</A></FONT>
and subsequent filings with the SEC. Any changes in such assumptions or factors could produce significantly different results. Undue
reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Except as required by applicable
law, the Company undertakes no obligation to update the forward-looking statements, whether as a result of new information, future events,
or otherwise.</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="pr_003"></A> MDU RESOURCES GROUP,
INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 1in; text-indent: 0.25in"><A NAME="a_Hlk197950194"></A>The Company is a pure-play
regulated energy delivery business upon the completed separations of both its construction materials and contracting and construction
services businesses. Montana-Dakota Utilities Co. (formerly known as MDU Resources Group, Inc., &ldquo;Montana-Dakota&rdquo;) was incorporated
under the laws of the state of Delaware in 1924. The Company was incorporated under the laws of the state of Delaware in 2018. Upon the
completion of an internal holding company reorganization, Montana-Dakota became a subsidiary of the Company. Our principal executive offices
are located at 1200&thinsp;West Century Avenue, P.O.&thinsp;Box&thinsp;5650, Bismarck, North Dakota 58506-5650, telephone (701)&thinsp;530-1000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>


<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_RISK_FACTORS"></A><A NAME="pr_004"></A>RISK FACTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 1in; text-indent: 0.25in"><FONT STYLE="background-color: white">An investment
in our securities involves risks. You should carefully consider the risks described in the sections entitled &ldquo;Risk Factors&rdquo;
in any prospectus supplement and those set forth in documents incorporated by reference in this prospectus and any applicable prospectus
supplement, including the risk factors set forth in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on
Form 10-Q or Current Reports on Form 8-K that we file after the date of this prospectus, as well as other information in this prospectus
and any applicable prospectus supplement, before purchasing any of our securities. Each of the risks described in these sections and documents
could materially and adversely affect our business, financial condition, results of operations and prospects, and could result in a loss
of your investment. Additional risks and uncertainties not known to us or that we deem immaterial may also impair our business, financial
condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&thinsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="pr_005"></A>USE OF PROCEEDS</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 1in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Unless
otherwise indicated in the applicable prospectus supplement, we intend to use the net proceeds from the sale of any securities offered
by us under this prospectus for general corporate purposes, which may include repayment or refinancing of debt, acquisitions, working
capital, capital expenditures, and repurchases or redemptions of securities. We will retain broad discretion over the allocation of net
proceeds from the sale of any securities offered by us</FONT>.</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="pr_006"></A>DESCRIPTION OF CAPITAL STOCK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><I>The following description of our capital stock
is intended as a summary only. This description is based upon, and is qualified by reference to, our Amended and Restated Certificate
of Incorporation, as amended to date (our &ldquo;certificate of incorporation&rdquo;), our Bylaws, as amended and restated to date (our
&ldquo;bylaws&rdquo;), and applicable provisions of the General Corporation Law of the State of Delaware (the &ldquo;DGCL&rdquo;). This
summary is not complete. You should read our&thinsp;</I><A HREF="http://www.sec.gov/Archives/edgar/data/67716/000006771619000045/ex32-amendedandrestatedcer.htm"><I>certificate
of incorporation</I></A><I>&thinsp;and our&thinsp;</I><A HREF="https://www.sec.gov/Archives/edgar/data/67716/000006771625000012/exhibit31mdurbylaws.htm"><I>bylaws</I></A><I>,
which are incorporated by reference as exhibits to the registration statement of which this prospectus forms a part, for the provisions
that are important to you.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Authorized and Outstanding Capital Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our certificate of incorporation authorizes us to
issue 502,000,000 shares of stock, divided into two classes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>500,000,000 shares of common stock, $1.00 par value per share; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>2,000,000 shares of preferred stock, $100 par value per share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><A NAME="a_Hlk204937704"></A>As of July 31, 2025,
we had 204,331,170 shares of common stock and no shares of preferred stock issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Dividend Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Subject to preferences that may be applicable to any
then outstanding preferred stock, holders of our common stock are entitled to receive dividends, if any, as may be declared from time
to time by our Board of Directors (the &ldquo;Board&rdquo;) out of legally available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Voting Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our common stock has one vote per share. The holders
of our common stock are entitled to vote on all matters to be voted on by stockholders. The holders of our common stock do not have cumulative
voting rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our bylaws provide for a majority voting standard
for the election of directors in an uncontested election and a plurality voting standard in the event the number of nominees exceeds the
number of directors to be elected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Liquidation Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Upon our liquidation, dissolution or winding up and
after payment in full of all amounts required to be paid to creditors and to the holders of preferred stock having liquidation preferences,
if any, the holders of our common stock will be entitled to receive pro rata our remaining assets available for distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Other Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Holders of our common stock do not have preemptive,
subscription, redemption or conversion rights. Our common stock is not liable to further calls or assessment. There are no redemption
or sinking fund provisions applicable to the common stock. All shares of our common stock that are outstanding are fully paid and non-assessable.
The rights, powers, preferences and privileges of holders of our common stock are subject to and may be adversely affected by the rights
of the holders of any shares of our preferred stock we may authorize and issue in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our certificate of incorporation authorizes our Board
to issue up to 2,000,000 shares of preferred stock, from time to time in one or more classes or series, generally without any vote or
action by the holders of our common stock. Our Board will be authorized to determine the number of shares and designation of any class
or series of preferred stock and the powers, rights, preferences and privileges of each class or series of preferred stock, including,
the dividend rate, dividend rights, conversion rights and terms, voting rights, redemption rights and terms, liquidation preferences
and sinking fund terms of any class or series of preferred stock, which may be greater than the rights of the holders of the common stock.
There are no shares of preferred stock outstanding.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The purpose of authorizing our Board to issue preferred
stock and determine its rights and preferences is to eliminate delays associated with a shareholder vote on specific issuances. The issuance
of preferred stock, while providing flexibility in connection with possible acquisitions, future financings and other corporate purposes,
could have the effect of making it more difficult for a third party to acquire, or could discourage a third party from seeking to acquire,
a majority of our outstanding voting stock. Additionally, the issuance of preferred stock may adversely affect the holders of our common
stock by restricting dividends on our common stock, diluting the voting power of our common stock or subordinating the liquidation rights
of our common stock. As a result of these or other factors, the issuance of preferred stock could have an adverse impact on the market
price of our common stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Provisions of our Certificate of Incorporation and our Bylaws and Certain
Provisions of Delaware Law That Could Delay or Prevent a Change in Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our certificate of incorporation, bylaws and the DGCL,
which are summarized in the following paragraphs, contain provisions that are intended to enhance the likelihood of continuity and stability
in the composition of our Board. These provisions are intended to avoid costly takeover battles, reduce our vulnerability to a hostile
change of control and enhance the ability of our Board to maximize shareholder value in connection with any unsolicited offer to acquire
us. However, these provisions may have an anti-takeover effect and may delay, deter or prevent a merger or acquisition of our company
by means of a tender offer, a proxy contest or other takeover attempt that a shareholder might consider in its best interest, including
those attempts that might result in a premium over the prevailing market price for the shares of common stock held by shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Authorized but Unissued Capital Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The authorized but unissued shares of common stock
and preferred stock are available for future issuance without shareholder approval, subject to any limitations imposed by the listing
rules of the NYSE. These additional shares may be used for a variety of corporate finance transactions, acquisitions and employee benefit
plans. The existence of authorized but unissued and unreserved common stock and preferred stock could make more difficult or discourage
an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Number of Directors, Vacancies, Removal of Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our certificate of incorporation provides that our
Board will have at least six and at most 15 directors. A majority of the Board decides the exact number of directors at a given time.
A majority of the directors then in office fill any new directorships created by the Board and any vacancies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Under the laws of the state of Delaware, our directors
may be removed by a majority of the shares then entitled to vote in an election of directors. However, our certificate of incorporation
provides that any action required or permitted to be taken by our stockholders, which includes the removal of directors, must be effected
at a duly called annual or special meeting of stockholders and may not be effected by any consent in writing by such stockholders. Our
certificate of incorporation prevents stockholders from calling a special meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>No Cumulative Voting</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Under Delaware law, the right to vote cumulatively
does not exist unless the certificate of incorporation specifically authorizes cumulative voting. Our certificate of incorporation does
not provide for cumulative voting. Accordingly, a holder or group of holders of a majority of the shares of our common stock are able
to elect all of the directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Requirements for Advance Notification of Shareholder Meetings, Director
Nominations and Shareholder Proposals</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our bylaws require that for a stockholder to nominate
a director or bring other business before an annual meeting, the stockholder must give notice not earlier than the close of business
on the 120th day prior to the first anniversary of the preceding year&rsquo;s annual meeting of stockholders and not later than the close
of business on the 90th day prior to the first anniversary of the prior year&rsquo;s annual meeting of stockholders. In order for any
matter to be &ldquo;properly brought&rdquo; before an annual meeting, a stockholder will have to comply with these advance notice requirements
and provide us with certain information. Stockholders at an annual meeting may only consider proposals or nominations specified in the
notice of meeting or brought before the meeting by or at the direction of our Board or by a qualified stockholder of record on the record
date for the meeting, who is entitled to vote at the meeting and who has delivered timely written notice in proper form to our secretary
of the stockholder&rsquo;s intention to bring such business before the meeting. These provisions could have the effect of delaying stockholder
actions that are favored by the holders of a majority of our outstanding voting securities until the next stockholder meeting.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">In addition, our bylaws also provide for proxy access,
pursuant to which a qualifying stockholder, or a group of up to 20 such stockholders, owning at least 3% of our outstanding common stock
continuously for at least three years, will generally be able to nominate and include in our proxy materials for an annual meeting of
stockholders, qualifying director nominees constituting up to the greater of two nominees or 20% of the total number of directors of the
Company; provided that the qualifying stockholder(s) and director nominee(s) satisfy the eligibility, procedural and other requirements
specified in our bylaws, including that notice of a nomination be delivered to our secretary not less than 120 days or more than 150 days
before the first anniversary of the date that we first sent our proxy statement to stockholders for the prior year&rsquo;s annual meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Stockholder Action by Written Consent; Special Meeting of Stockholders</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our certificate of incorporation eliminates the ability
of stockholders to act by written consent. Our bylaws provide that special meetings of our stockholders may be called only by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>Provisions of Delaware Law That Could Delay or Prevent a Change in
Control</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&#9;We are subject to the provisions of Section 203 of the DGCL. With some
exceptions, this law prohibits us from engaging in some types of business combinations with a person who owns 15% or more of our outstanding
voting stock for a three-year period after that person acquires the stock. This prohibition does not apply if:&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>our Board approved the business combination or the transaction of our stock before the person became an interested stockholder;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>upon consummation of the transaction that resulted in the person becoming an interested stockholder, that person owned at least 85%
of our outstanding voting stock outstanding at the time of the transaction, excluding certain shares; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>at or subsequent to such time the business combination is approved by the Board and by at least two-thirds of the outstanding voting
stock not owned by the interested stockholder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">A &ldquo;business combination&rdquo; includes, among
other things, a merger or consolidation involving us and the &ldquo;interested stockholder&rdquo; and the sale of more than 10% of our
assets. In general, an &ldquo;interested stockholder&rdquo; is any entity or person beneficially owning 15% or more of our outstanding
voting stock and any entity or person affiliated with or controlling or controlled by such entity or person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Forum Selection</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our bylaws provide that, unless we consent in writing
to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for any
Internal Corporate Claims. As defined in our bylaws, &ldquo;Internal Corporate Claims&rdquo; means claims, including claims in the right
of the Company, (i) that are based upon a violation of a duty by a current or former director or officer or stockholder in such capacity,
or (ii) as to which the DGCL confers jurisdiction upon the Court of Chancery of the State of Delaware. Although we have included a choice
of forum clause in our bylaws, it is possible that a court could rule that such clause is inapplicable or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Transfer Agent; Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">The transfer agent and registrar for our common stock
is EQ Shareowner Services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">Our common stock is listed on the NYSE and trades
under the symbol &ldquo;MDU.&rdquo;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="pr_007"></A>DESCRIPTION OF DEBT SECURITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We may issue debt securities from time to time under
this prospectus. We will set forth in an accompanying prospectus supplement a description of the debt securities that may be offered under
this prospectus. <FONT STYLE="background-color: white">The debt securities will be issued under one or more indentures, which may include
existing indentures. </FONT>The applicable prospectus supplement and other offering material relating to such offering will describe the
specific terms relating to the series of debt securities being offered, including a description of the material terms of the indenture
(and any supplemental indentures) governing such series. These terms may include the following:</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the title of the series of the offered debt securities;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the price or prices at which the offered debt securities will be issued;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>any limit on the aggregate principal amount of the offered debt securities;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the date or dates on which the principal of the offered debt securities will be payable;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the rate or rates (which may be fixed or variable) per year at which the offered debt securities will bear interest, if any, or the
method of determining the rate or rates and the date or dates from which interest, if any, will accrue;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>if the amount of principal, premium or interest with respect to the offered debt securities of the series may be determined with reference
to an index or pursuant to a formula, the manner in which these amounts will be determined;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the date or dates on which interest, if any, on the offered debt securities will be payable and the regular record dates for the payment
thereof;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the place or places, if any, in addition to or instead of the corporate trust office of the trustee, where the principal, premium
and interest with respect to the offered debt securities will be payable;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the period or periods, if any, within which, the price or prices of which, and the terms and conditions upon which the offered debt
securities may be redeemed, in whole or in part, pursuant to optional redemption provisions;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the terms on which we would be required to redeem or purchase the offered debt securities pursuant to any sinking fund or similar
provision, and the period or periods within which, the price or prices at which and the terms and conditions on which the offered debt
securities will be so redeemed and purchased in whole or in part;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the denominations in which the offered debt securities will be issued;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the form of the offered debt securities and whether the offered debt securities are to be issued in whole or in part in the form of
one or more global securities and, if so, the identity of the depositary for the global security or securities;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the portion of the principal amount of the offered debt securities that is payable on the declaration of acceleration of the maturity,
if other than their principal amount;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>if other than U.S. dollars, the currency or currencies in which the offered debt securities will be denominated and payable, and the
holders&rsquo; rights, if any, to elect payment in a foreign currency or a foreign currency unit other than that in which the offered
debt securities are otherwise payable;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>whether the offered debt securities will be issued with guarantees and, if so, the terms of any guarantee of the payment of principal
and interest with respect to the offered debt securities;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>any addition to, or modification or deletion of, any event of default or any covenant specified in the indenture;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>whether the offered debt securities will be convertible or exchangeable into other securities, and if so, the terms and conditions
upon which the offered debt securities will be convertible or exchangeable;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>whether the offered debt securities will be senior or subordinated debt securities;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>any trustees, authenticating or paying agents, transfer agents or registrars or other agents with respect to the offered debt securities;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>any other specific terms of the offered debt securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&thinsp;</B></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="pr_008"></A>DESCRIPTION OF WARRANTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0.25in">We may issue warrants for
the purchase of debt securities, common stock, preferred stock or other securities. Warrants may be issued independently or together with
debt securities, common stock, preferred stock or other securities offered by any prospectus supplement and may be attached to or separate
from any such offered securities. Each series of warrants will be issued under a separate warrant agreement to be entered into between
us and a bank or trust company, as warrant agent, all as will be set forth in the prospectus supplement relating to the particular issue
of warrants. The warrant agent will act solely as our agent in connection with the warrants and will not assume any obligation or relationship
of agency or trust for or with any holders of warrants or beneficial owners of warrants. The summary of the terms of the warrants contained
in this prospectus is not complete and is subject to, and is qualified in its entirety to, all provisions of the applicable warrant agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0.25in">Reference is made to the
prospectus supplement relating to the particular issue of warrants offered pursuant to such prospectus supplement for the terms of and
information relating to such warrants, which may include:</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; background-color: white">&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the specific designation and aggregate number of, and the offering price
at which we will issue, the warrants;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the currency or currency units in which the offering price, if any, and the
exercise price are payable;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the date on which the right to exercise the warrants will begin and the date
on which that right will expire or, if the holder may not continuously exercise the warrants throughout that period, the specific date
or dates on which the holder may exercise the warrants;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">whether the warrants are to be sold separately or with other securities as
parts of units;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">whether the warrants will be issued in definitive or global form or in any
combination of these forms, although, in any case, the form of a warrant included in a unit will correspond to the form of the unit and
of any security included in that unit;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">any applicable material U.S. federal income tax consequences;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the identity of the warrant agent for the warrants and of any other depositaries,
execution or paying agents, transfer agents, registrars or other agents;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the proposed listing, if any, of the warrants or any securities purchasable
upon exercise of the warrants on any securities exchange;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the designation and terms of any equity securities purchasable upon exercise
of the warrants;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the designation, aggregate principal amount, currency and terms of any debt
securities that may be purchased upon exercise of the warrants;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">if applicable, the designation and terms of the debt securities, preferred
stock, depositary shares or common stock with which the warrants are issued and the number of warrants issued with each security;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">if applicable, the date from and after which any warrants issued as part
of a unit and the related debt securities, preferred stock or common stock will be separately transferable;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the number of shares of preferred stock, the number of shares of common stock
purchasable upon exercise of a warrant and the price at which those shares may be purchased;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">if applicable, the minimum or maximum amount of the warrants that may be
exercised at any one time;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">information with respect to book-entry procedures, if any;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the antidilution provisions of, and other provisions for changes to or adjustment
in the exercise price of, the warrants, if any;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">any redemption or call provisions; and&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">any additional terms of the warrants, including terms, procedures and limitations
relating to the exchange or exercise of the warrants.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&thinsp;</B></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="pr_009"></A>DESCRIPTION OF PURCHASE CONTRACTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0.25in">We may issue, from time to
time, purchase contracts, including contracts obligating holders to purchase from us and us to sell to the holders, a specified principal
amount of debt securities, shares of common stock or preferred stock, or any of the other securities that we may sell under this prospectus
at a future date or dates. The consideration payable upon settlement of the purchase contracts may be fixed at the time the purchase contracts
are issued or may be determined by a specific reference to a formula set forth in the purchase contracts. The purchase contracts may be
issued separately or as part of units consisting of a purchase contract and other securities or obligations issued by us or third parties,
including United States treasury securities, securing the holders' obligations to purchase the relevant securities under the purchase
contracts. The purchase contracts may require us to make periodic payments to the holders of the purchase contracts or units or vice versa,
and the payments may be unsecured or prefunded on some basis. The purchase contracts may require holders to secure their obligations under
the purchase contracts. The summary of the terms of the purchase contracts contained in this prospectus is not complete and is subject
to, and is qualified in its entirety by, all provisions of the applicable purchase contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 1in; background-color: white; text-indent: 0.25in">The prospectus supplement
related to any particular purchase contracts will describe, among other things, the material terms of the purchase contracts and of the
securities being sold pursuant to such purchase contracts, a discussion, if appropriate, of any special U.S. federal income tax considerations
applicable to the purchase contracts and any material provisions governing the purchase contracts that differ from those described above.
The description in the prospectus supplement will not necessarily be complete and will be qualified in its entirety by reference to the
purchase contracts, and, if applicable, collateral arrangements and depositary arrangements, relating to the purchase contracts.</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="pr_010"></A>DESCRIPTION OF UNITS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0.25in">We may, from time to time,
issue units comprised of one or more of the other securities that may be offered under this prospectus, in any combination. Each unit
may also include debt obligations of third parties, such as U.S. Treasury securities. Each unit will be issued so that the holder of the
unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder
of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not
be held or transferred separately at any time, or at any time before a specified date or other specific circumstances occur. The summary
of the terms of the units contained in this prospectus is not complete and is subject to, and is qualified in its entirety by, all provisions
of the applicable unit agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0.25in">Any prospectus supplement
related to any particular units will describe, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the material terms of the units and of the securities comprising the units,
including whether and under what circumstances those securities may be held or transferred separately;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">any material provisions relating to the issuance, payment, settlement, transfer
or exchange of the units or of the securities comprising the units;&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">if appropriate, any special U.S. federal income tax considerations applicable
to the units; and&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">any material provisions of the governing unit agreement that differ from
those described above.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 1in; background-color: white; text-indent: 0.25in">The applicable provisions
described in this section, as well as those described under &ldquo;Description of Capital Stock,&rdquo; &ldquo;Description of Debt Securities,&rdquo;
&ldquo;Description of Warrants&rdquo; and &ldquo;Description of Purchase Contracts,&rdquo; will apply to each unit and to each security
included in each unit, respectively.</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="pr_011"></A>PLAN OF DISTRIBUTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">We may sell the securities
being offered hereby:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">directly to purchasers;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through agents;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through dealers;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through underwriters;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through a combination of any of the above methods of sale;
or</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&thinsp;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through any other methods described in a prospectus supplement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">We will identify the specific
plan of distribution, including any direct purchasers, agents, dealers, underwriters and, if applicable, their compensation, the purchase
price, the net proceeds to us, the public offering price, and any discounts or concessions allowed or reallowed or paid to dealers, in
a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">The distribution of securities
may be effected, from time to time, in one or more transactions, including block transactions and transactions on the NYSE or any other
organized market where the securities may be traded. The securities may be sold at a fixed price or prices, which may be changed, or at
market prices prevailing at the time of sale, at prices relating to the prevailing market prices or at negotiated prices. The consideration
may be cash or another form negotiated by the parties. Agents, underwriters or broker-dealers may be paid compensation for offering and
selling the securities. That compensation may be in the form of discounts, concessions or commissions to be received from us or from the
purchasers of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">We may also make sales of
our common stock in transactions that are deemed to be &ldquo;at the market offerings,&rdquo; as defined in Rule 415(a)(4) under the Securities
Act, including sales made by means of ordinary brokers&rsquo; transactions on the NYSE at market prices, or otherwise as agreed between
us and one or more underwriters, dealers or agents. If we engage in such transactions, we will do so pursuant to the terms of a distribution
agreement between us and the underwriters, dealers or agents. If we engage in at-the-market sales pursuant to a distribution agreement,
we will issue and sell shares of our common stock to or through one or more underwriters, dealers or agents, which may act on an agency
basis or on a principal basis. During the term of any such distribution agreement, we may sell shares on a daily basis in exchange transactions
or otherwise as we agree with the underwriters, dealers or agent. The distribution agreement may provide that any shares of our common
stock sold will be sold at prices related to the then prevailing market prices for our securities. Pursuant to the terms of the distribution
agreement, we also may agree to sell, and the relevant underwriters, dealers or agents may agree to solicit offers to purchase, blocks
of our common stock. The terms of each such distribution agreement will be set forth in more detail in a prospectus supplement to this
prospectus. To the extent that any named underwriter, dealer or agent acts as principal pursuant to the terms of a distribution agreement,
or if we offer to sell shares of our common stock through another dealer acting as underwriter, then such named underwriter may engage
in certain transactions that stabilize, maintain or otherwise affect the price of our common stock. We will describe any such activities
in the prospectus supplement relating to the transaction. To the extent that any named dealer or agent acts as agent on a best efforts
basis pursuant to the terms of a distribution agreement, such dealer or agent will not engage in any such stabilization transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">Offers to purchase the securities
may be solicited directly by us or by agents designated by us from time to time. We will, in the prospectus supplement relating to an
offering, name any agent that could be viewed as an underwriter under the Securities Act and describe any commissions we must pay. Any
such agent will be acting on a best efforts basis for the period of its appointment or, if indicated in the applicable prospectus supplement,
on a firm commitment basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">If a dealer is utilized in
the sale of the securities in respect of which this prospectus is delivered, we will sell the securities to the dealer, as principal.
The dealer, which may be deemed to be an underwriter as that term is defined in the Securities Act, may then resell the securities to
the public at varying prices to be determined by the dealer at the time of resale. Dealer trading may take place in certain of the securities,
including securities not listed on any securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">If an underwriter or underwriters
are utilized in the sale, we will execute an underwriting or similar agreement with the underwriters at the time of sale to them and the
names of the underwriters will be set forth in the applicable prospectus supplement, which will be used by the underwriters to make resales
of the securities in respect of which this prospectus is delivered to the public. The obligations of underwriters to purchase securities
will be subject to certain conditions precedent and the underwriters will be obligated to purchase all of the securities of a series if
any are purchased.</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">We may directly solicit offers
to purchase the securities and we may make sales of securities directly to institutional investors or others. These persons may be deemed
to be underwriters within the meaning of the Securities Act with respect to any resale of the securities. To the extent required, the
prospectus supplement will describe the terms of any such sales, including the terms of any bidding or auction process, if used.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">Underwriters, dealers, agents
and other persons may be entitled, under agreements that may be entered into with us, to indemnification against certain civil liabilities,
including liabilities under the Securities Act, or to contribution with respect to payments that they may be required to make in respect
thereof. Underwriters, dealers and agents may engage in transactions with, or perform services for, us in the ordinary course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">Any person participating
in the distribution of common stock registered under the registration statement that includes this prospectus will be subject to applicable
provisions of the Exchange Act, and the applicable SEC rules and regulations, including, among others, Regulation&thinsp;M, which may limit
the timing of purchases and sales of our common stock by any such person. Furthermore, Regulation&thinsp;M may restrict the ability of any
person engaged in the distribution of our common stock to engage in market-making activities with respect to our common stock. These restrictions
may affect the marketability of our common stock and the ability of any person or entity to engage in market-making activities with respect
to our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in; background-color: white">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 1in; text-indent: 0.25in; background-color: white">Except as described above,
in order to facilitate the offering of the securities, any underwriters may engage in transactions that stabilize, maintain or otherwise
affect the price of the securities or any other securities the prices of which may be used to determine payments on such securities. Specifically,
any underwriters may overallot in connection with the offering, creating a short position for their own accounts. In addition, to cover
overallotments or to stabilize the price of the securities or of any such other securities, the underwriters may bid for, and purchase,
the securities or any such other securities in the open market. Finally, in any offering of the securities through a syndicate of underwriters,
the underwriting syndicate may reclaim selling concessions allowed to an underwriter or a dealer for distributing the securities in the
offering if the syndicate repurchases previously distributed securities in transactions to cover syndicate short positions, in stabilization
transactions or otherwise. Any of these activities may stabilize or maintain the market price of the securities above independent market
levels. Any such underwriters are not required to engage in these activities and may end any of these activities at any time.</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="pr_012"></A>WHERE YOU CAN FIND MORE INFORMATION<FONT STYLE="font-weight: normal">&thinsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0.25in">&thinsp;&thinsp;&thinsp;&thinsp;&thinsp;&thinsp;&thinsp;&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0.25in">We file annual, quarterly
and current reports, proxy statements and other information with the SEC. Our SEC filings are available over the Internet at the SEC&rsquo;s
web site at www.sec.gov. Our filings with the SEC are also available free of charge on our website at www.mdu.com. The information on
our website (or any other website referred to in this prospectus or any applicable prospectus supplement) is not incorporated by reference
in this prospectus or any prospectus supplement and you should not consider it a part of this prospectus or any accompanying prospectus
supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center; background-color: white"><B>&thinsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="pr_013"></A>INFORMATION INCORPORATED BY REFERENCE</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; text-indent: 0.25in"><FONT STYLE="background-color: white">The
SEC allows us to &ldquo;incorporate by reference&rdquo; the information we file with them, which means that we can disclose important
information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus
and any accompanying prospectus supplement, and later information filed with the SEC will automatically update and supersede this information.
We incorporate by reference the documents listed below and all documents subsequently filed with the SEC pursuant to Sections&thinsp;13(a),
13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering under this prospectus and any prospectus supplement (other
than information deemed furnished and not filed in accordance with SEC rules, including Items&thinsp;2.02 and 7.01 of Form&thinsp;8-K):</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; background-color: white">&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><A NAME="a_Hlk198193306"></A>&#9679;</TD><TD><FONT STYLE="font-size: 10pt">our </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000016/mdu-20241231.htm"><FONT STYLE="font-size: 10pt">Annual
Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 20, 2025</FONT></A><FONT STYLE="font-size: 10pt">;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><A NAME="a_Hlk198193321"></A>&#9679;</TD><TD><FONT STYLE="font-size: 10pt">the Part III information contained in our </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000031/mdu-20250402.htm"><FONT STYLE="font-size: 10pt">definitive
proxy statement on Schedule 14A for our 2025 annual meeting of stockholders, filed with the SEC on April 3, 2025</FONT></A><FONT STYLE="font-size: 10pt">,
that was incorporated into our </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000016/mdu-20241231.htm"><FONT STYLE="font-size: 10pt">Annual
Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 20, 2025</FONT></A><FONT STYLE="font-size: 10pt">;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt">our <FONT STYLE="background-color: white">Quarterly Reports on Form&thinsp;10-Q for the quarters ended
</FONT></FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000042/mdu-20250331.htm"><FONT STYLE="font-size: 10pt; background-color: white">March
31, 2025</FONT></A> <A NAME="a_Hlk201135370"></A><FONT STYLE="font-size: 10pt">and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/67716/000006771625000074/mdu-20250630.htm">June 30, 2025</A></FONT><FONT STYLE="font-size: 10pt; background-color: white">,
filed with the SEC on May 8, 2025 and August </FONT><FONT STYLE="font-size: 10pt">7, 2025, respectively<FONT STYLE="background-color: white">;
</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white">&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt; background-color: white">our Current Reports on Form&thinsp;8-K filed with the SEC on </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000067716/000006771625000012/mdu-20250214.htm"><FONT STYLE="font-size: 10pt; background-color: white">February
14, 2025</FONT></A> <FONT STYLE="font-size: 10pt"><A NAME="a_Hlk201135410"></A>and </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/67716/000006771625000052/mdu-20250513.htm"><FONT STYLE="font-size: 10pt">May
15, 2025</FONT></A><FONT STYLE="font-size: 10pt; background-color: white">; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD><FONT STYLE="font-size: 10pt; background-color: white">the description of our securities contained in </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/67716/000110465919000026/a18-41510_6ex99db.htm#Exhibit99b_015209"><FONT STYLE="font-size: 10pt; background-color: white">Exhibit
99(b)</FONT></A> <FONT STYLE="font-size: 10pt; background-color: white">to our Current Report on Form 8-K12B, filed with the SEC on January
2, 2019, including any amendments or reports filed for the purpose of updating such description (including </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/67716/000006771620000010/a2019ex4g.htm"><FONT STYLE="font-size: 10pt; background-color: white">Exhibit
4(a)</FONT></A> <FONT STYLE="font-size: 10pt; background-color: white">to our Annual Report on Form 10-K for the year ended December 31,
2019, filed with the SEC on February 21, 2020).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">We will provide to each person, including any beneficial
owner, to whom a copy of this prospectus is delivered, a copy of any or all of the information that has been incorporated by reference
in this prospectus but not delivered with this prospectus. We will provide this information upon written or oral request at no cost to
the requester. You should direct your requests to:</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in">Office of the Treasurer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in">MDU Resources Group, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in">1200 West Century Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in">P.O. Box 5650</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in">Bismarck, North Dakota 58506-5650</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 1in; text-indent: 1.5in">Telephone: (701) 530-1000</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="pr_014"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="background-color: white">Unless the applicable
prospectus supplement indicates otherwise, the validity of the securities offered by this prospectus will be passed upon for us by Perkins
Coie&thinsp;LLP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center"><B>&thinsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="pr_015"></A>EXPERTS</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&thinsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 1in; text-indent: 0.5in">The financial statements of MDU Resources Group, Inc.
incorporated by reference in this Prospectus, and the effectiveness of MDU Resources Group, Inc.&rsquo;s internal control over financial
reporting have been audited by Deloitte &amp; Touche LLP, an independent registered public accounting firm, as stated in their reports.
Such financial statements are incorporated by reference in reliance upon the reports of such firm, given their authority as experts in
accounting and auditing.</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&thinsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&thinsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&thinsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 24pt 0 0; text-align: center"><FONT STYLE="font-size: 18pt"><B>Up to $400,000,000
</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="text-align: center; font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><IMG SRC="mduresourceslogo.jpg" ALT=""></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 24pt 0 0; text-align: center"><FONT STYLE="font-size: 24pt"><B>MDU Resources
Group, Inc.</B></FONT><B> </B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 24pt 0 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Common Stock
</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>PROSPECTUS SUPPLEMENT
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>August 7,
2025</B></FONT></P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center"><FONT STYLE="font-size: 16pt"><B>Wells Fargo
Securities</B></FONT><B> </B></P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 16pt"><B>BofA Securities
</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0">&thinsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 18pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid; width: 100%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exh_107-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:CIK0000067716="http://mduresources.com/20250807">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_027_FFD%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_CIK0000067716_mduresources.com_20250807 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20250807_20250807 -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0000067716 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body>
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-08-07" id="Fact000003" name="dei:EntityCentralIndexKey">0000067716</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-07" id="xdx2ixbrl0009" name="ffd:FeeExhibitTp">EX-FILING FEES</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-07" id="xdx2ixbrl0010" name="ffd:SubmissnTp">424B5</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-08-072025-08-07_1" id="xdx2ixbrl0018" name="ffd:OfferingSctyTp">Equity</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2025-08-072025-08-07_2" id="xdx2ixbrl0023" name="ffd:OfferingSctyTp">Equity</ix:nonNumeric>
  <ix:nonFraction name="ffd:FeeAmt" contextRef="From2025-08-072025-08-07_2" id="xdx2ixbrl0028" decimals="2" scale="0" unitRef="USD">0.00</ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-08-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000067716</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-07</xbrli:startDate>
        <xbrli:endDate>2025-08-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-08-072025-08-07_1">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000067716</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ffd:OfferingAxis">
            <dei:lineNo>1</dei:lineNo>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-07</xbrli:startDate>
        <xbrli:endDate>2025-08-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-08-072025-08-07_2">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000067716</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:typedMember dimension="ffd:OfferingAxis">
            <dei:lineNo>2</dei:lineNo>
          </xbrldi:typedMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-07</xbrli:startDate>
        <xbrli:endDate>2025-08-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0.25in; text-align: right"><span id="xdx_905_effd--FeeExhibitTp_dxL_c20250807__20250807_zmUWEJNUk52l" title="::XDX::EX-FILING FEES"><span style="-sec-ix-hidden: xdx2ixbrl0009">EXHIBIT 107</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">Calculation of Filing Fee Tables</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><span id="xdx_901_effd--SubmissnTp_dxL_c20250807__20250807_zYb9CPp8nx33" title="::XDX::424B5"><span style="-sec-ix-hidden: xdx2ixbrl0010">424(b)(5)</span></span><br/>
(Form Type)<span style="display: none"><span id="xdx_90C_effd--FormTp_c20250807__20250807_zLfjiqdjbdJ3"><ix:nonNumeric contextRef="AsOf2025-08-07" id="Fact000011" name="ffd:FormTp">S-3</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><span id="xdx_904_edei--EntityRegistrantName_c20250807__20250807_zAiTnWR9TSVh"><ix:nonNumeric contextRef="AsOf2025-08-07" id="Fact000012" name="dei:EntityRegistrantName">MDU RESOURCES GROUP, INC.</ix:nonNumeric></span><br/>
(Exact Name of Registrant as Specified in its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><span id="xdx_908_effd--RegnFileNb_c20250807__20250807_z26CFOscDO2f" style="display: none"><ix:nonNumeric contextRef="AsOf2025-08-07" id="Fact000013" name="ffd:RegnFileNb">333-289348</ix:nonNumeric></span><span style="text-decoration: underline">Table 1: Newly Registered and Carry Forward
Securities <span id="xdx_909_effd--CombinedProspectusTableNa_c20250807__20250807_zmxPqoS5yyBg"><span id="xdx_907_effd--OffsetTableNa_c20250807__20250807_zb82qeihMB8k" style="display: none"><ix:nonNumeric contextRef="AsOf2025-08-07" id="Fact000014" name="ffd:CombinedProspectusTableNa"><ix:nonNumeric contextRef="AsOf2025-08-07" id="Fact000015" name="ffd:OffsetTableNa">N/A</ix:nonNumeric></ix:nonNumeric></span></span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 16%"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: top; width: 5%; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 5%"><p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 9pt"><b>Security</b></span></p>
    <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 9pt"><b>Type</b></span></p></td>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 7%; text-align: center"><span style="font-size: 9pt"><b>Security
    Class Title</b></span></td>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 8%; text-align: center"><span style="font-size: 9pt"><b>Fee
    Calculation or Carry Forward Rule</b></span></td>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 7%; text-align: center"><span style="font-size: 9pt"><b>Amount
    Registered</b></span></td>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 7%; text-align: center"><span style="font-size: 9pt"><b>Proposed
    Maximum Offering Price Per Unit</b></span></td>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 7%; text-align: center"><span style="font-size: 9pt"><b>Maximum
    Aggregate Offering Price</b></span></td>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 7%; text-align: center"><span style="font-size: 9pt"><b>Fee
    Rate</b></span></td>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 5%; text-align: center"><span style="font-size: 9pt"><b>Amount
    of Registration Fee</b></span></td>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 6%; text-align: center"><span style="font-size: 9pt"><b>Carry
    Forward Form Type</b></span></td>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 6%; text-align: center"><span style="font-size: 9pt"><b>Carry
    Forward File Number</b></span></td>
    <td style="border-top: Black 1.5pt double; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 6%; text-align: center"><span style="font-size: 9pt"><b>Carry
    Forward Initial Effective Date</b></span></td>
    <td style="border-top: Black 1.5pt double; border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: bottom; width: 8%; text-align: center"><span style="font-size: 9pt"><b>Filing
    Fee Previously Paid In Connection with Unsold Securities to be Carried Forward</b></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="14" style="border-right: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt"><b>Newly
    Registered Securities</b></span></td></tr>
  <tr>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt"><b><span id="xdx_909_effd--PrevslyPdFlg_dbT_c20250807__20250807__ffd--OfferingAxis__1_z4gGvcfJT78j"><span id="xdx_900_effd--PrevslyPdFlg_dbF_c20250807__20250807__ffd--OfferingAxis__2_zZ6JJVPAHlF7"><ix:nonNumeric contextRef="From2025-08-072025-08-07_1" format="ixt:booleantrue" id="Fact000016" name="ffd:PrevslyPdFlg"><ix:nonNumeric contextRef="From2025-08-072025-08-07_2" format="ixt:booleanfalse" id="Fact000017" name="ffd:PrevslyPdFlg">Fees
    to be Paid</ix:nonNumeric></ix:nonNumeric></span></span></b></span></td>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">(1)</span></td>
    <td id="xdx_98A_effd--OfferingSctyTp_dxL_c20250807__20250807__ffd--OfferingAxis__1_zCAXIdsJJEn7" title="::XDX::Equity" style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0018">Equity</span></span></td>
    <td id="xdx_98E_effd--OfferingSctyTitl_c20250807__20250807__ffd--OfferingAxis__1_z8DnajQzQ8fl" style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-08-072025-08-07_1" id="Fact000019" name="ffd:OfferingSctyTitl">Common
    Stock, par value $1.00 per share</ix:nonNumeric></span></td>
    <td id="xdx_981_effd--FeesOthrRuleFlg_dbT_c20250807__20250807__ffd--OfferingAxis__1_zp09J1iJ8NE8" style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-08-072025-08-07_1" format="ixt:booleantrue" id="Fact000020" name="ffd:FeesOthrRuleFlg">Other</ix:nonNumeric></span></td>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td id="xdx_98B_effd--MaxAggtOfferingPric_pp2p0_c20250807__20250807__ffd--OfferingAxis__1_zWFO6EHRk4og" style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">$<ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="From2025-08-072025-08-07_1" id="Fact000021" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">306,204,908.98</ix:nonFraction></span></td>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">0.0001531</span></td>
    <td id="xdx_98C_effd--FeeAmt_pp2p0_uUSD_c20250807__20250807__ffd--OfferingAxis__1_zzokSQbouMc2" style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">$<ix:nonFraction name="ffd:FeeAmt" contextRef="From2025-08-072025-08-07_1" id="Fact000022" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">46,879.97</ix:nonFraction></span></td>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td></tr>
  <tr>
    <td style="border-left: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt"><b>Fees
    Previously Paid</b></span></td>
    <td style="border-left: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-right: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="14" style="border-top: Black 1.5pt solid; border-right: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt"><b>Carry
    Forward Securities</b></span></td></tr>
  <tr>
    <td style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt"><b>Carry
    Forward Securities</b></span></td>
    <td style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">(2)</span></td>
    <td id="xdx_98F_effd--OfferingSctyTp_dxL_c20250807__20250807__ffd--OfferingAxis__2_zS395TuI6cu7" title="::XDX::Equity" style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl0023">Equity</span></span></td>
    <td id="xdx_98E_effd--OfferingSctyTitl_c20250807__20250807__ffd--OfferingAxis__2_zw5ivJTbIQHe" style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-08-072025-08-07_2" id="Fact000024" name="ffd:OfferingSctyTitl">Common
    Stock, par value $1.00 per share</ix:nonNumeric></span></td>
    <td id="xdx_982_effd--FeesOthrRuleFlg_dbT_c20250807__20250807__ffd--OfferingAxis__2_zFiSndyRN3I2" style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-08-072025-08-07_2" format="ixt:booleantrue" id="Fact000025" name="ffd:FeesOthrRuleFlg">Rule
    415(a)(6)</ix:nonNumeric></span></td>
    <td id="xdx_986_effd--AmtSctiesRegd_c20250807__20250807__ffd--OfferingAxis__2_zk7SseyCdLP1" style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt"><ix:nonFraction name="ffd:AmtSctiesRegd" contextRef="From2025-08-072025-08-07_2" id="Fact000026" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,570,426</ix:nonFraction></span></td>
    <td style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td id="xdx_984_effd--MaxAggtOfferingPric_pp2p0_c20250807__20250807__ffd--OfferingAxis__2_zU1y2QfqcXG4" style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">$<ix:nonFraction name="ffd:MaxAggtOfferingPric" contextRef="From2025-08-072025-08-07_2" id="Fact000027" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">93,795,091.02</ix:nonFraction></span></td>
    <td style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td id="xdx_985_effd--FeeAmt_pp2p0_dxL_uUSD_c20250807__20250807__ffd--OfferingAxis__2_zUtP5C9ANEVh" title="::XDX::0.00" style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="-sec-ix-hidden: xdx2ixbrl0028"><span style="font-size: 9pt">&#8201;</span></span></td>
    <td style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90E_effd--CfwdFormTp_c20250807__20250807__ffd--OfferingAxis__2_zEnfb9rolyse"><ix:nonNumeric contextRef="From2025-08-072025-08-07_2" id="Fact000029" name="ffd:CfwdFormTp">S-3</ix:nonNumeric></span>ASR</span></td>
    <td id="xdx_984_effd--CfwdPrrFileNb_c20250807__20250807__ffd--OfferingAxis__2_zBSapplv5VL2" style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt"><ix:nonNumeric contextRef="From2025-08-072025-08-07_2" id="Fact000030" name="ffd:CfwdPrrFileNb">333-289348</ix:nonNumeric></span></td>
    <td style="border-top: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90B_effd--CfwdPrrFctvDt_dd_c20250807__20250807__ffd--OfferingAxis__2_zpRRFI6wIQrl"><ix:nonNumeric contextRef="From2025-08-072025-08-07_2" format="ixt:datemonthdayyear" id="Fact000031" name="ffd:CfwdPrrFctvDt">8/7/2025</ix:nonNumeric></span></span></td>
    <td id="xdx_987_effd--CfwdPrevslyPdFee_pp2p0_c20250807__20250807__ffd--OfferingAxis__2_z64GnhY6aIpi" style="border-top: Black 1.5pt solid; border-right: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">$<ix:nonFraction name="ffd:CfwdPrevslyPdFee" contextRef="From2025-08-072025-08-07_2" id="Fact000032" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">11,367.97</ix:nonFraction></span></td></tr>
  <tr>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td colspan="4" style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt"><b>Total
    Offering Amounts</b></span></td>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td id="xdx_98A_effd--TtlOfferingAmt_c20250807__20250807_zNqxedv6gaEf" style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; text-align: center"><span style="font-size: 9pt">$<ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="AsOf2025-08-07" id="Fact000033" format="ixt:numdotdecimal" decimals="0" unitRef="USD">400,000,000</ix:nonFraction></span></td>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td id="xdx_989_effd--TtlFeeAmt_pp2p0_uUSD_c20250807__20250807_zNZ4fvzSqVd4" style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt">$<ix:nonFraction name="ffd:TtlFeeAmt" contextRef="AsOf2025-08-07" id="Fact000034" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">46,879.97</ix:nonFraction>
    </span></td>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-top: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td colspan="4" style="border-bottom: Black 1pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt"><b>Total
    Fees Previously Paid</b></span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td id="xdx_988_effd--TtlPrevslyPdAmt_uUSD_c20250807__20250807_ztn0PafUP5J8" style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt">$<ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="AsOf2025-08-07" id="Fact000035" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0.00</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td colspan="4" style="border-bottom: Black 1pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt"><b>Total
    Fee Offsets</b></span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td id="xdx_987_effd--TtlOffsetAmt_uUSD_c20250807__20250807_zHfQPLAAj8r9" style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt">$<ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="AsOf2025-08-07" id="Fact000036" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0.00</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td></tr>
  <tr>
    <td style="border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt">&#8201;</span></td>
    <td colspan="4" style="border-bottom: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt"><b>Net
    Fee Due</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td id="xdx_98D_effd--NetFeeAmt_pp2p0_uUSD_c20250807__20250807_zO4CG6DDnhO1" style="border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt; vertical-align: top; text-align: center"><span style="font-size: 9pt">$<ix:nonFraction name="ffd:NetFeeAmt" contextRef="AsOf2025-08-07" id="Fact000037" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">46,879.97</ix:nonFraction>
    </span></td>
    <td style="border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td>
    <td style="border-right: Black 1.5pt solid; border-bottom: Black 1.5pt solid; border-left: Black 1.5pt solid; padding: 3pt"><span style="font-size: 9pt">&#8201;</span></td></tr>
  </table>
<ix:nonNumeric contextRef="From2025-08-072025-08-07_1" escape="true" id="Fact000039" name="ffd:OfferingNote"><p id="xdx_846_effd--OfferingNote_hffd--OfferingAxis__1_dU_zx8Pk70J3l7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#8201;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">1.</td><td>The registration fee is calculated in accordance with Rule 457(o) of the Securities Act of 1933 as amended, (the "Securities
Act") based on the proposed maximum aggregate offering price and Rule 457(r) of the Securities Act, which in accordance with Rule
456(b) and 457(r) under the Securities Act represents deferred payment of the registration fees in connection with the shelf registration
statement on Form S-3 (File No. 333-289348) (the &#8220;2025 Registration Statement&#8221;) filed by the Registrant on August 7, 2025,
which was automatically effective upon its filing with the Securities and Exchange Commission (the &#8220;Commission&#8221;).</td></tr></table>

</ix:nonNumeric><ix:nonNumeric contextRef="From2025-08-072025-08-07_2" escape="true" id="Fact000041" name="ffd:OfferingNote"><p id="xdx_849_effd--OfferingNote_hffd--OfferingAxis__2_dU_zWlFShl7Mw45" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0in">&#8201;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">2.</td><td>On February 22, 2019, the registrant filed a prospectus supplement to the base prospectus contained in the registrant&#8217;s registration
statement on Form S-3 (File No. 333-220026), which became effective upon its filing with the Commission on August 18, 2017, as amended
by Post-Effective Amendment No. 1, filed with the Commission on January 2, 2019, in connection with the registrant&#8217;s prior &#8220;at-the-market&#8221;
offering program (the &#8220;ATM Program&#8221;). In connection with such prospectus supplement, the registrant paid a filing fee of $31,839.24
to register the offering of up to 10,000,000 shares of the registrant&#8217;s common stock for a proposed maximum aggregate offering price
of $262,700,000. Pursuant to Rule 415(a)(6), 6,398,889 shares of common stock representing a proposed maximum aggregate offering price
of $168,098,814 registered in connection with the ATM Program remained unsold and were registered on the registrant&#8217;s registration
statement on Form S-3 (File No. 333-246323), which became effective upon its filing with the Commission on August 14, 2020 (the &#8220;Prior
Registration Statement&#8221;). As of August 7, 2025, 3,570,426 of the 6,398,889 shares of common stock representing a proposed maximum
aggregate offering price of</td></tr></table>


<ix:exclude><!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>
<ix:exclude><p id="xdx_234_zb2cgfZS0dlg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0.25in; text-align: right">EXHIBIT 107</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">$93,795,091.02 registered for sale pursuant to the Prior Registration
Statement remained unsold (the &#8220;Unsold Securities&#8221;) and were registered on the 2025 Registration Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in">&#8201;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-indent: 0in">Pursuant to Rule 415(a)(6), the Unsold
Securities are being carried forward and the $11,367.97 filing fee previously paid in connection with the Unsold Securities (based on
the filing fee rates in effect at the time such Unsold Securities were initially registered) will continue to be applied to the Unsold
Securities under this prospectus supplement, and no additional filing fee is due with respect to the Unsold Securities in connection with
the filing of this prospectus supplement.</p>

</ix:nonNumeric><p id="xdx_85A_zr81Mp69014h" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <div style="border-bottom: Black 2pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LVs3mD+7dKiIU8YQ8ba4KMWtGWn9eyTf0rohhkBIzvlyhBiJFS11gwzHeVXAHtuuUQ6hwjMymhN6R77eZOBnhRdtHSvj+vUH5uQZ9Mw4jJW/9867tlhnIKeRnERJCnKSpTMotyL46jmZs67ROK0aUKaGkqljjU7xa/iwV08y1L76pAOy1WQyiEM5yG9IZJzAju7qQXy1UBS5CEZ9BWLFdOu8a/F0aL4kLBpsfZwd6H8HH9QySms= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>mduresourceslogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mduresourceslogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  T :4# 2(  A$! Q$!_\0
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M_P 2RXZGM2?\(QK?_0+N/RJ?9R["Y'V,FM_P7_R-EE]7_P#035;_ (1C6_\
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M._:H?$OPC\<>)M4EN+[Q'97$0ED:WCF9_P!TI/  "X'&/RH O_L\?\BYK/\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>5
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Aug. 07, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000067716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">MDU RESOURCES GROUP, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-289348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Aug. 07, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common
    Stock, par value $1.00 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 306,204,908.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 46,879.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><p id="xdx_846_effd--OfferingNote_hffd--OfferingAxis__1_dU_zx8Pk70J3l7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#8201;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">1.</td><td>The registration fee is calculated in accordance with Rule 457(o) of the Securities Act of 1933 as amended, (the "Securities
Act") based on the proposed maximum aggregate offering price and Rule 457(r) of the Securities Act, which in accordance with Rule
456(b) and 457(r) under the Securities Act represents deferred payment of the registration fees in connection with the shelf registration
statement on Form S-3 (File No. 333-289348) (the &#8220;2025 Registration Statement&#8221;) filed by the Registrant on August 7, 2025,
which was automatically effective upon its filing with the Securities and Exchange Commission (the &#8220;Commission&#8221;).</td></tr></table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common
    Stock, par value $1.00 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">3,570,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 93,795,091.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-289348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">Aug.  07,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrevslyPdFee', window );">Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</a></td>
<td class="nump">$ 11,367.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><p id="xdx_849_effd--OfferingNote_hffd--OfferingAxis__2_dU_zWlFShl7Mw45" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0in">&#8201;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">2.</td><td>On February 22, 2019, the registrant filed a prospectus supplement to the base prospectus contained in the registrant&#8217;s registration
statement on Form S-3 (File No. 333-220026), which became effective upon its filing with the Commission on August 18, 2017, as amended
by Post-Effective Amendment No. 1, filed with the Commission on January 2, 2019, in connection with the registrant&#8217;s prior &#8220;at-the-market&#8221;
offering program (the &#8220;ATM Program&#8221;). In connection with such prospectus supplement, the registrant paid a filing fee of $31,839.24
to register the offering of up to 10,000,000 shares of the registrant&#8217;s common stock for a proposed maximum aggregate offering price
of $262,700,000. Pursuant to Rule 415(a)(6), 6,398,889 shares of common stock representing a proposed maximum aggregate offering price
of $168,098,814 registered in connection with the ATM Program remained unsold and were registered on the registrant&#8217;s registration
statement on Form S-3 (File No. 333-246323), which became effective upon its filing with the Commission on August 14, 2020 (the &#8220;Prior
Registration Statement&#8221;). As of August 7, 2025, 3,570,426 of the 6,398,889 shares of common stock representing a proposed maximum
aggregate offering price of</td></tr></table>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">$93,795,091.02 registered for sale pursuant to the Prior Registration
Statement remained unsold (the &#8220;Unsold Securities&#8221;) and were registered on the 2025 Registration Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in">&#8201;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-indent: 0in">Pursuant to Rule 415(a)(6), the Unsold
Securities are being carried forward and the $11,367.97 filing fee previously paid in connection with the Unsold Securities (based on
the filing fee rates in effect at the time such Unsold Securities were initially registered) will continue to be applied to the Unsold
Securities under this prospectus supplement, and no additional filing fee is due with respect to the Unsold Securities in connection with
the filing of this prospectus supplement.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdFormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., "Form S-3" in the human-readable and "S-3ASR" in the XBRL).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdFormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:formTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrevslyPdFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrevslyPdFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrrFctvDt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrrFctvDt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrrFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrrFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Aug. 07, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">46,879.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 46,879.97<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="exh_107-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exh_107-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="exh_107-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exh_107-filingfees.htm">exh_107-filingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exh_107-filingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exh_107-filingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/dei/2025": 1,
    "http://xbrl.sec.gov/ffd/2025": 5
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 30,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-08-07",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exh_107-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-08-07",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exh_107-filingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2025-08-072025-08-07_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exh_107-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-08-072025-08-07_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exh_107-filingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2025-08-07",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exh_107-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-08-07",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exh_107-filingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001539497-25-002056-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001539497-25-002056-xbrl.zip
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M@D]AQ0.WB\5E\!WFV9@M$?@5:10)U(I@; L"I7>R+"X2S5BPM?5YCY(7 S.
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MW]61*1B@"-/M "L*?#N@3UAHXX-^UD5)<C^'W*GXN#=-98F,J>-Q?Q] 6C7
ME%(#35%$W<3@3<YOK  Z)$XM=4@D%X]S!]'T,CI6Q,$=XO=S@%72+*#6@]C7
M"-$FX2&FILB2-T+!0Q)[W6&NC#+4U>^Q0>2!J+CN;@/VV<C_'<EW5! I4WX
M9DHZ5#__][]%@>,//-$2Z=WQ!(@]AG)_KPIO'Y?'B-YR5&WZQL;KI8(MA'38
MKS@1<'Z8[H=\C<GJU:FA=56$DH^@NL(V%AH0/F.OIHBF">*$ZC4D@O?/?G%+
M]F%R87,>G'H8X12-.M:'D\>VYE"=:)9*&'-^U?*'\ [UAZZ96&+LG8LS>6)-
MD-N^0VTH##!J8P/=J#+Y0T3B2(%Q5QV-##P2"8[(Y \1A1LI.B"!#\;R5M5+
M.!@$9I0L1H(T/I@0\EL*@:4"QIN;#KSVRY\K 9@Q(Y@L];'QQ\J@!5E %A74
M@& X(/(]1O7GBPRL1[Q*&N^^KF*]6UM@&-*F@>]ES3*5.6J+,A4>JFFJBNV5
M"5.9C"&KFK2;'&B'$ WU,2O%:./*D7M4P/ _PYD5N^3$3.02OB)@+DWO/DK0
M)D18*X]*?4V9;B,PUBF*U%T!8:Q@>VT;>R4+8O/F;42PK/U%C0<LIRTUE5%/
MZE_'=JMZ;E?+>]C:Z_&]A^SHR_U@>'I=*-XN]L*X> 3-M1$(O8>?^=/3;^WJ
MB=(LK&Q7K5IL9"_8/$K(,U+N:YJ"1948%H[TM/+!GE:0Y.WP"K%XAZ)B1A$7
MEB,&WS:9^=F^2GU[T][:=O'RA6QY8[/=Y?=BR?>,K%CU&ZZ!=5M+'R0ML>-:
M]4=+,D]/&VIAX7D?6P 6C67O5F)K/P8K^FO;PA83+^=&G)Q!4)M(N5A7Q=NK
MAZOB4/DX\MQ^@:/GX:6E"PQ!@(E*39M,-)7)O$NTP5T2:#;0O:A8&/W%[W,<
MTNE:&[HL8*FWQRN-]Q]ZFY=D;-!.RQ917N=*I[Q\6KQH%']WO:V5*P0NLCHW
M*-Q$!3[0PGT-37T063ZAT_X16/#]Y=CQEW-Q5AV-B.L(M _3TW5!YS;QFN_-
MRWSCI'.7U48?QFO^6KZJ.48F:RYQCH1#(>)FJC61-.*L>%YSZ7.&RR<%+ILL
M<<7]4G%A$?1'ME2ZJIOC<QG^$5NM^;&].B&.>5KT/8P-;/1!N^M>]37K?"#\
M#C:ZT<K[J%D*3S?+;#Y9+)3V2X7?RB)_\_#_N['P2LC7:)&\=H?#FRY'^F%K
MSH)?E=SU+?+-#>J3@D\*/BGX6!1\8EL#V_,\D'A2ZGSR0Y5'ZI6W?.:R^%#O
M)1^XO':QL0EW+\K1YDUUX;&F>O/I376A]]#-E'+75BL_L)ZGJ?[6+7,A\\HM
M<Y#A-"??GU[W6U<G^+U(:_N7[KVI=O:M&N+",S3$02M-N:M*\\Y%IK5IV^2=
M:66]=G=N9;N;_L)$G>5SN^+>;GYO0Z7D':54)P1L ,)G!X^D3=1Q5^B:>%Z3
MSMK\^U)'3(LJQ.1F>T1X^LBOV:EJ730#'2KW-=E,,E?@DEDA_P)-JK=MWV>?
MK7T/1G7#SX6KX:_!CR^;UEP?JCD?M:W"T[N@I4RR4,HEN1*$:N&W,[)<7-^=
M5D8;]=ZI@9%VKE:J7C2^C:/E$7T&\$9&MZK^*6XHP/>JZ.A");=0JPVGTHK7
M=Y?HL:$.^R5#4^;FZC?VUG;!T'(!GZ95+_E6NYTU8R.%US:,%2^'+F'SN"OJ
MNG*?^W;VP6N>H*PS7%36GFS6>6'U_9OV<43M W)?)SUIH_)*[W2:K?RT=64H
MSU)H2B+!4-^3L23.YU@T(BKAXU3"Z$Y4BND"VXGJL55O\3Y0" G#76B'\>;%
M03[[11W_FQ=;NOQ1&C(KJH>H/+8K'3+/\ "5YY.9?.&Q!ZCO9G7N*SZR>_FG
M3EZ3<=-Z=X4P7ZCW=JT146&$>^]*V2_3/%/G[>W-8W&!ZS51O# $=6?LE@(7
MOV98NL^/Q,;P=UC.$68YL?;^!'2/F+4BT>("#HY+<O:_][N$XUG,JN2;U7HK
MB!XN?F:']P_=7]^D9PP0;]&\7VUQ<6N(5AI;]B77#3D[;'U\R_LD]_U4$R^R
MV"<BA#?6V*9O^+UM1-JN+%O*PHM77?09P):+K-Z7F7Q2$U\=%/WJP)L8TAIA
M>75 5*XM#F_:N=.%=T3>E:NM3OY!9C<H 7+;UINQ6WA_ $OYI.9]):*WS^B_
MA1C_X'R.[&W\UFV@O"\G^Z1F=</;;J2 >E?G\)/A5?NL6KTM&J4/G,,]3C=(
MX.NNJ/A,X'\<->',\W'3]UMW)=YPTYTW3.*O\##D A,OB=>M=;=(>F_6\4G/
M\C1>=](X:'K-7OUEMO8E7Z^KX\N%%9'OS,M6Y'*/W0T2^3,L7WMZ,_[M;>>3
MGO>8F9Z0YM-L7W3[F,,MMC7!8.STF+;%Q=V9V,UI+C1"%[/I7A J9O.1MQGH
MD-XX=EL!Z:;W,"NV[PK<:48IX,AV[1N=?A"02F1[^.!V\-'MXC?&%]H?WD9N
M/_3AO(^N#0!)C[ZW%3 Q!S*72%=BOF7GUR0J_+ZM;?AW/<;("&X%.H2T+IMH
MX.R@;)\Q(0X&8'?T\%Y[=S^Z!A]E<X5=;8_N)4H 2&"GO^J T&_Y4B9#3ZL
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=965S+FAT;5!+!08      0 ! $0   #Z$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>exh_107-filingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="AsOf2025-08-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000067716</identifier>
        </entity>
        <period>
            <startDate>2025-08-07</startDate>
            <endDate>2025-08-07</endDate>
        </period>
    </context>
    <context id="From2025-08-072025-08-07_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000067716</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-07</startDate>
            <endDate>2025-08-07</endDate>
        </period>
    </context>
    <context id="From2025-08-072025-08-07_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000067716</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-07</startDate>
            <endDate>2025-08-07</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-08-07" id="Fact000003">0000067716</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="AsOf2025-08-07" id="xdx2ixbrl0009">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:SubmissnTp contextRef="AsOf2025-08-07" id="xdx2ixbrl0010">424B5</ffd:SubmissnTp>
    <ffd:OfferingSctyTp contextRef="From2025-08-072025-08-07_1" id="xdx2ixbrl0018">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTp contextRef="From2025-08-072025-08-07_2" id="xdx2ixbrl0023">Equity</ffd:OfferingSctyTp>
    <ffd:FeeAmt
      contextRef="From2025-08-072025-08-07_2"
      decimals="2"
      id="xdx2ixbrl0028"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:FormTp contextRef="AsOf2025-08-07" id="Fact000011">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="AsOf2025-08-07" id="Fact000012">MDU RESOURCES GROUP, INC.</dei:EntityRegistrantName>
    <ffd:RegnFileNb contextRef="AsOf2025-08-07" id="Fact000013">333-289348</ffd:RegnFileNb>
    <ffd:CombinedProspectusTableNa contextRef="AsOf2025-08-07" id="Fact000014">N/A</ffd:CombinedProspectusTableNa>
    <ffd:OffsetTableNa contextRef="AsOf2025-08-07" id="Fact000015">N/A</ffd:OffsetTableNa>
    <ffd:PrevslyPdFlg contextRef="From2025-08-072025-08-07_1" id="Fact000016">true</ffd:PrevslyPdFlg>
    <ffd:PrevslyPdFlg contextRef="From2025-08-072025-08-07_2" id="Fact000017">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTitl contextRef="From2025-08-072025-08-07_1" id="Fact000019">Common     Stock, par value $1.00 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="From2025-08-072025-08-07_1" id="Fact000020">true</ffd:FeesOthrRuleFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="From2025-08-072025-08-07_1"
      decimals="2"
      id="Fact000021"
      unitRef="USD">306204908.98</ffd:MaxAggtOfferingPric>
    <ffd:FeeAmt
      contextRef="From2025-08-072025-08-07_1"
      decimals="2"
      id="Fact000022"
      unitRef="USD">46879.97</ffd:FeeAmt>
    <ffd:OfferingSctyTitl contextRef="From2025-08-072025-08-07_2" id="Fact000024">Common     Stock, par value $1.00 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="From2025-08-072025-08-07_2" id="Fact000025">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="From2025-08-072025-08-07_2"
      decimals="INF"
      id="Fact000026"
      unitRef="Shares">3570426</ffd:AmtSctiesRegd>
    <ffd:MaxAggtOfferingPric
      contextRef="From2025-08-072025-08-07_2"
      decimals="2"
      id="Fact000027"
      unitRef="USD">93795091.02</ffd:MaxAggtOfferingPric>
    <ffd:CfwdFormTp contextRef="From2025-08-072025-08-07_2" id="Fact000029">S-3</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="From2025-08-072025-08-07_2" id="Fact000030">333-289348</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="From2025-08-072025-08-07_2" id="Fact000031">2025-08-07</ffd:CfwdPrrFctvDt>
    <ffd:CfwdPrevslyPdFee
      contextRef="From2025-08-072025-08-07_2"
      decimals="2"
      id="Fact000032"
      unitRef="USD">11367.97</ffd:CfwdPrevslyPdFee>
    <ffd:TtlOfferingAmt
      contextRef="AsOf2025-08-07"
      decimals="0"
      id="Fact000033"
      unitRef="USD">400000000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="AsOf2025-08-07"
      decimals="2"
      id="Fact000034"
      unitRef="USD">46879.97</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="AsOf2025-08-07"
      decimals="0"
      id="Fact000035"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="AsOf2025-08-07"
      decimals="0"
      id="Fact000036"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="AsOf2025-08-07"
      decimals="2"
      id="Fact000037"
      unitRef="USD">46879.97</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="From2025-08-072025-08-07_1" id="Fact000039">&lt;p id="xdx_846_effd--OfferingNote_hffd--OfferingAxis__1_dU_zx8Pk70J3l7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#x2009;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;1.&lt;/td&gt;&lt;td&gt;The registration fee is calculated in accordance with Rule 457(o) of the Securities Act of 1933 as amended, (the "Securities
Act") based on the proposed maximum aggregate offering price and Rule 457(r) of the Securities Act, which in accordance with Rule
456(b) and 457(r) under the Securities Act represents deferred payment of the registration fees in connection with the shelf registration
statement on Form S-3 (File No. 333-289348) (the &#x201c;2025 Registration Statement&#x201d;) filed by the Registrant on August 7, 2025,
which was automatically effective upon its filing with the Securities and Exchange Commission (the &#x201c;Commission&#x201d;).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="From2025-08-072025-08-07_2" id="Fact000041">&lt;p id="xdx_849_effd--OfferingNote_hffd--OfferingAxis__2_dU_zWlFShl7Mw45" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0in"&gt;&#x2009;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;2.&lt;/td&gt;&lt;td&gt;On February 22, 2019, the registrant filed a prospectus supplement to the base prospectus contained in the registrant&#x2019;s registration
statement on Form S-3 (File No. 333-220026), which became effective upon its filing with the Commission on August 18, 2017, as amended
by Post-Effective Amendment No. 1, filed with the Commission on January 2, 2019, in connection with the registrant&#x2019;s prior &#x201c;at-the-market&#x201d;
offering program (the &#x201c;ATM Program&#x201d;). In connection with such prospectus supplement, the registrant paid a filing fee of $31,839.24
to register the offering of up to 10,000,000 shares of the registrant&#x2019;s common stock for a proposed maximum aggregate offering price
of $262,700,000. Pursuant to Rule 415(a)(6), 6,398,889 shares of common stock representing a proposed maximum aggregate offering price
of $168,098,814 registered in connection with the ATM Program remained unsold and were registered on the registrant&#x2019;s registration
statement on Form S-3 (File No. 333-246323), which became effective upon its filing with the Commission on August 14, 2020 (the &#x201c;Prior
Registration Statement&#x201d;). As of August 7, 2025, 3,570,426 of the 6,398,889 shares of common stock representing a proposed maximum
aggregate offering price of&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;$93,795,091.02 registered for sale pursuant to the Prior Registration
Statement remained unsold (the &#x201c;Unsold Securities&#x201d;) and were registered on the 2025 Registration Statement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0in"&gt;&#x2009;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-indent: 0in"&gt;Pursuant to Rule 415(a)(6), the Unsold
Securities are being carried forward and the $11,367.97 filing fee previously paid in connection with the Unsold Securities (based on
the filing fee rates in effect at the time such Unsold Securities were initially registered) will continue to be applied to the Unsold
Securities under this prospectus supplement, and no additional filing fee is due with respect to the Unsold Securities in connection with
the filing of this prospectus supplement.&lt;/p&gt;

</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
